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ABSTRACT 
Experimental autoimmune thyroiditis (EAT) induced in mice following 
challenge with thyroglobulin (Tg) in adjuvant, serves as a model for Hashimoto's 
thyroiditis (HT). Earlier work in our laboratory established that EAT can be 
induced in mice following challenge with a 17mer MTg(2495-11) or an 1Smer 
MTg(2695-13) peptide, in complete Freunds adjuvant: (2495-11) peptide induced 
thyroiditis in H-2k, s haplotypes while (2695-13) peptide induced disease only in 
H-2s haplotype. In the present study, truncation analysis using a panel of 
peptide-specific TCR a~+ Cn4+ ens- T-cell hybridomas from EAT-susceptible 
C3H mice, identified two overlapping 9mer minimal determinants (2496-04) and 
(2499-07) within MTg(2495-11). The Ek-restricted (2496-04) determinant was 
immunogenic and pathogenic not only in C3H but also in SJL mice. Further, the 
determinants within MTg(2495-11) recognized by AS -restricted SJL T cells were 
mapped identical to those restricted by the Ek and Ak molecules. MTg(2496-04)-
primed lymph node cells (LNC) secreted IL-2, IFN-y but not IL-4 upon specific 
activation in vitro, suggesting that induction of Th1 cells follows priming with the 
minimal Tg peptide in SJL mice. In addition, TCR-V~ 2, 4 and 17 genes were 
utilized by a panel of ten MTg(2496-04)-specific IL-2-secreting hybrid T -cell 
clones generated from this Th1 subset, thus providing the first evidence of 
multiple TCR-V~ gene usage in EAT induced with a minimal Tg epitope. In 
parallel, work involving the 1Smer MTg(2695-13) peptide established a panel of 
TCR a~+ Cn4+ ens- IL-2 secreting T-cell hybridomas from SJL mice. Using 
two AS-restricted (2695-13)-specific T-cell hybrids and three overlapping 12mer 
peptides spanning the core, N- and C- terminal regions of MTg(2695-13), two 
iii 
distinct T -cell determinants were localized within the 18mer peptide. The N-
terminal 12mer (2695-06) was highly immunogenic and induced severe EAT 
following adoptive transfer of peptide-specific Thl cells. A human homologue of 
MTg(2695-06) carrying two Ser substitutions of GLn2703 and Thr2704, on the 
other hand, showed contrasting immunopathogenic properties: it failed to 
activate Thl cells; it did not cross-react. wit!l MTg~2695-06)-specific T cells and 
induced only mild thyroiditis. These findings highlight caution against 
extrapolating the epitope mapping data across heterologous Tgs despite their 
high homology. Finally, a computer search of SWIS5-PROT data bank to identify 
sequences highly homologous with pathogenic Tg determinants, has led to 
identification of a 14mer adenoviral E1B(368-81) peptide (A VP). The viral 
peptide cross-reacted significantly with MTg(2696-04) at B- and T- cell level. 
A VP, however, failed to induce specific B- or T- cell responses. Despite its poor 
immunogenicity, AVP, when used as an Ag in vitro, conferred the EAT-inducing 
ability on MTg(2696-04)- primed LNC in adoptive transfer experiments. These 
findings suggest that viral peptides, such as A VP, when generated during 
infection, can amplify autoreactive T cells (via molecular mimicry) present in the 
host and thus, precipitate autoimmune thyroid disease. 
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1. Thyroid gland 
CHAPTER 1 
INTRODUCTION 
1. 1 Structure and Physiology 
The thyroid gland is specialized to synthesize, store and release thyroid 
hormones (T 3 and T 4). In humans, it consists of two pear-shaped lobes that lie on 
either side of the trachea. Both lobes are joined by an isthmus that lies over the 
second to fourth tracheal rings. The thyroid follicle (200-300 llffi in diameter), a 
spheroidal structure lined by parenchymal epithelium, encloses the protein 
thyroglobulin (Tg) and is the functional unit of the thyroid gland. The shape of 
the follicular epithelial cells changes from normal cuboidal to columnar under 
excessive stimulation with thyroid stimulating hormone (TSH) (McDougall, 
1992). Iodide (1-) is selectively concentrated within thyrocytes and transported 
transepithelially into the follicular lumen by means of specific mechanisms 
(Nilsson 1995). In an extracellular process catalyzed by thyroid peroxidase (TPO), 
I- is oxidized and coupled to tyrosine residues on the Tg resulting in the 
formation of monoiodotyrosine (MIT) and diiodotyrosine (DIT). Although large 
amounts of MIT and DIT are generated, coupling of only some iodinated 
tyrosines occurs at fixed positions on the Tg molecule. Synthesis and release of 
thyroid hormones is basically under the control of TSH secreted by the anterior 
pituitary. TSH not only serves to maintain active iodide transport and iodide 
peroxidase system but also it stimulates hormonogenesis through a cAMP-
responsive system and a phosphatidyl-inositol system (DeGroot et al., 1996). In 
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addition to the Tg, which comprises 70-80% of the protein, the thyroid gland also 
contains other iodoproteins (2-13%) such as the thyroalbumin, an iodinated 
albumin-like protein containing MIT, DIT and iodothyronines that are believed 
to enter the thyroid gland from the serum (DeGroot et al., 1996). 
1. 2 Thyroidal antigens 
1. 2. 1 Thyroglobulin 
Thyroglobulin (Tg), a huge and highly conserved glycoprotein of 660 kD, 
encoded by a gene on chromosome 8 in humans, is synthesized in the 
endoplasmic reticulum of thyroid follicular cells (thyrocytes). After synthesis, Tg 
is post translationally modified in the Golgi complex, and eventually secreted 
into the follicular lumen (Van Herle et al., 1979; Ekholm and Bjorkman, 1990). 
Two monomers of human Tg (HTg) (17 5), each composed of 2748 residues (19 S 
if iodinated), are linked by disulfide bonds. Iodinated Tg tends to form 
aggregates while iodine deficiency causes Tg to dissociate more easily into 
subunits (Rossi et al., 1973) which are degraded by thyroid acid proteases (Lamas 
and Ingbar, 1978). Tg molecule has 140 tyrosyl residues, of which, about 40 can 
be iodinated and 8-10 are hormonogenic sites. However, Tg normally contains 
one T3 and two or three T4 molecules. Immunologically, Tg is not a sequestered 
antigen as it is continuously released along with T3 and T4 into the circulation 
(Carayanniotis and Rao, 1997). Based on internal homologies, the Tg sequence 
has been subdivided into 4 domains: Domain A has ten Tyr- and Cys- rich 
repeats of 50 a. a. each between positions 29 and 1196; Domain B has three 
repeats of 14-17 highly conserved residues between positions 1436-1483; Domain 
C has five repeats between positions 1583 and 2109; and Domain D lacks internal 
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homology (Medeiros-Neto et al., 1993). Amino acid (a. a.) sequence comparison 
of Tgs from human, bovine Tg (BTg) and rat Tg (RTg) (known portion) revealed: 
73-77% identity; 6-7% conservative substitutions and 16-19% dissimilarity 
(Carayanniotis and Rao, 1997). Due to this high homology between them, Tgs 
from various species cross-react at the B- or T- cell level. 
1. 2. 2 Thyroid peroxidase and thyroid stimulating hormone receptor 
Thyroid peroxidase (TPO), also now known as microsomal antigen, is an 
important enzyme that oxidizes iodide in the presence of H202 and is situated on 
the luminal surface of the microvilli of the thyrocytes. In 1957, Trotter and co-
workers described reactivity in sera from patients with autoimmune thyroid 
disease (AITD) to the 'thyroid microsomal antigen'. Several studies done in the 
mid 1980s had confirmed the identity between the microsomal antigen and the 
TPO (Czarnocka et al., 1985; Portmann et al., 1985 and 1988). TPO is a 
transmembrane glycoprotein, of 107 kD in size and 933 a. a. in length, encoded 
by a gene on chromosome 2p13. It shares 44% a. a. sequence similarity with 
myeloperoxidase and has domains similar to acetylcholinesterase and receptors 
of low density lipoprotein and insulin-like growth factors. Expression of TPO 
mRNA can be rapidly induced by TSH or cAMP through transcriptional 
activation (DeGroot et al., 1996). The two important steps in the biosynthesis of 
thyroid hormones that are controlled by TPO are: first, the iodination of tyrosine 
residues on Tg and second, the coupling of iodinated tyrosines to form T3 and T4. 
The presence of anti-TPO antibodies in the majority of patients with thyroid 
dysfunction seems to emphasize the possible role of this thyroidal antigen in 
AITD. 
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TSH receptor (TSH-R) is a 120 kD protein expressed on the thyrocytes, that 
binds to the TSH, the major trophic hormone for the thyroid. Encoded by a gene 
on chromosome 14, TSH-R is 764 a. a. in length and consists of seven 
hydrophobic transmembrane regions spanning 346 a. a. and an extracellular 
portion of 398 a. a. to which TSH binds. The extracellular N-terminal half of 
TSH-R of human, dog and rat share 85-90% homology (Naga¥s.lma and Rapoport, . 
1992). A !Orner (441-450) sequence of the cytoplasmic C-terminal of TSH-R was 
shown to be important in generating cAMP response (Chazenbalk et al., 1990) 
while N -terminal a. a. 38-45 sequence of the receptor had been shown to be 
crucial for TSH binding (Wadsworth et al., 1990). The extracellular portion of the 
TSH-R has been shown to be highly immunogenic confirming its importance in 
GD (Murakami and Mori, 1990). 
2. Thyroid autoimmunity 
2. 1 Autoimmune thyroid disorders: an overview 
AITD is considered an example of an organ-specific autoimmune 
phenomenon, although patients with autoimmune thyroid disease often exhibit 
certain associated syndromes including vitiligo, myasthenia gravis, pernicious 
anemia, rheumatoid arthritis and Sjogren's syndrome. The etiology of these 
disorders remains complex and their relationship to thyroid autoimmunity is 
unclear at present (DeGroot et al., 1996). An attempt has been made here to 
describe AITD from an immunological standpoint. 
Depending upon the presence or absence of specific peripheral blood 
lymphocytes sensitized to thyroidal Ag, human thyroid disorders have been 
classified as primary or secondary. The primary AITDs include: Graves' disease 
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(GD), Hashimoto's thyroiditis (HT), lymphocytic thyroiditis of childhood and 
adolescence, post-partum thyroiditis, chronic fibrous thyroiditis, idiopathic 
myxoedema and atrophic asymptomatic thyroiditis (Volpe, 1990). Among the 
various forms of autoimmune thyroid disorders, HT is the most common, 
affecting people of all ages and ·both sexes, although it is shown to occur more 
frequently in women of age 40-60 years (9-25 times higher) than in men of the 
same age (McDougall, 1992). GD has been recorded in people of all ages, 
however, it occurs seven times more commonly in women than men of 30-40 
years age (Dwyer, 1994). Despite the fact that GD and HT represent the opposite 
ends of the spectrum of thyroid function, co-occurrence of both the diseases in 
families and, clinical transition of one disorder to the other within the same 
individual over time have led some to believe they are pathogenetically related 
(DeGroot et al., 1996). However, others believe they are distinct entities (Volpe, 
1990, Dwyer, 1994). When large populations are compared, differences in HLA 
associations with GD or HT are apparent; e.g. HLA-DR3 was found to be 
associated with GO while HLA-DR4 or 5 was found in higher frequency in HT 
cases (Volpe, 1990). 
2. 2 Hashimoto's thyroiditis 
Since its first description as "struma lymphomatosa" in 1912 by Hashimoto 
to characterize the lymphocytic infiltration, eosinophilia of thyroid epithelium 
and interstitial fibrosis of thyroid glands of four middle aged women, the term 
Hashimoto's thyroiditis is now used to embrace other variants of thyroid disease 
including lymphocytic thyroiditis, postpartum thyroiditis, chronic fibrous 
thyroiditis, idiopathic myxedema etc. (Volpe, 1990). 
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Over forty years ago, Roitt et al., (1956) detected antibodies against Tg in 
sera of patients with HT, while Rose and Witebsky (1956) demonstrated 
induction of thyroiditis in rabbits following immunization with thyroid extract. 
The etiology of HT still remains elusive (Volpe, 1991) despite much progress in 
the characterization of autoimmune responses in general. 
Epidemiological studies indicated that HT prevalence is increasing. HT 
affects 0.5-1.2% of the general population and it is believed that there exist many 
subclinical cases with focal thyroiditis that can only be diagnosed by autopsy 
(Bigazzi, 1993). It is estimated that in most populations, 10% of individuals have 
positive Tg and TPO antibody. 
On clinical examination, most patients present with a thyroid gland that 
may be firm, nodular or diffusely enlarged but rarely painful and tender. There 
are usually no systemic symptoms unless the patient is severely hypothyroid 
(reviewed in McDougall 1992). Some may switch from a hypothyroid to 
hyperthyroid condition perhaps a process reflective of whether inhibiting or 
stimulating antibodies are produced (Sung and McDougall, 1978). Most patients 
with autoimmune thyroiditis have antibodies that can react in vitro with Tg, 
microsomal Ag or other cell surface autoantigens. The prevalence of anti-Tg Ab 
in HT patients seems to vary with their age. Juveniles affected with chronic 
lymphocytic thyroiditis show Ab to Tg and microsomal Ag (Burek et al., 1982). 
Although a total correlation exists between the incidence of chronic lymphocytic 
thyroiditis and the presence of Ab to Tg or microsomal Ag, the latter does not 
necessarily indicate disease occurrence (Burek and Bresler, 1990). On the other 
hand, Ab against Tg are rare in children without AITD. In the case of adults with 
HT, autoantibodies could be detected in 76- 100% patients (Bigazzi, 1993). Using 
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a radioimmunoassay, circulating antibodies were demonstrated in 86-100% of 
patients with autoimmune thyroiditis, 87-89% of patients with untreated GD and 
69-94% of patients with primary myxedema (Bigazzi and Rose, 1985). Although 
a large body of literature exists showing correlation between the presence of anti-
Tg Ab and thyroiditis in patients, it remains still unclear whether these responses 
occur seconda-rily.,.J0llowing thyroid damage or are involved in etiology of the 
disease. The observation that healthy subjects (8.7%) also have anti-Tg Ab 
(Bigazzi, 1993) and some patients with histological lesions of HT (Yoshida et al., 
1978) and others with thyroid autoimmunity (Tanner et al., 1982) have anti-TPO 
but not anti-Tg Ab further complicates this issue. 
The nature of Tg-epitopes recognized by Ab in patients' sera remains 
unclear. Nye et al., (1980) suggested that autoantibodies from different human 
sera recognized the same epitopes on human Tg. On the other hand, through the 
use of mouse mAbs eight different autoepitopes on HTg were determined by 
Rose and coworkers (reviewed in Bigazzi and Rose, 1985). In addition, six 
distinct clusters of reactivity were described by Ruf and co-workers (1983) using 
a panel of mouse m.Ab to HTg. Based on the observation that pooled serum from 
48 GD patients reacted only with one of the six clusters, they suggested that 
certain selected regions of the Tg molecule bear pathogenic epitopes. Studies by 
Bouanani et al., (1989) revealed that sera from healthy subjects contained anti-Tg 
Ab that bound to a domain distinct from that recognized by serum from subjects 
with AlTO. Another study by Henry et al., (1992), identified an immuno-
dominant domain (a. a. 1149-1250) in the central part of HTg recognized by sera 
from patients with AITD. In addition, patients with AlTO were shown to have 
Abs that react with TPO (Doble et al., 1988; Kaufman et al., 1989), "second colloid 
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antigen" (van Trotsenburg et al., 1989), thyroid cell surface antigens (Bigazzi, 
1993) and TSH receptor (Zakarija and McKenzie, 1990). 
Histopathology of thyroid glands, in general, is characterized by the 
presence of inflammatory cells (lymphocytes, plasma cells and macrophages), 
distorted follicles and fibrosis (focal or extensive). Electron microscopic studies 
showed dilatation of capillaries and damage to the basement membranes of the 
thyroid follicles. Hyperplasia and a tall columnar nature of the follicular cells is 
observed in the goitrous form of thyroiditis. In some cases, thyroid cells become 
packed with mitochondria and assume an acidophile staining and are known as 
Hurthle or Askanazy cells (reviewed in DeGroot, 1996). 
Among the intrathyroidallymphocytes (lTL), CD4+ and cytolytic CDS+ cells 
were found; activated B cells were also shown to be increased in some patients 
(reviewed in Volpe 1991). In some studies immune complexes formed between 
Tg and its Ab were demonstrated around the basement membrane of the 
follicular cells. It is also believed that formation of such complexes and their 
subsequent removal by the thyroid might be responsible for low levels of anti-Tg 
Ab in patient sera (reviewed in DeGroot, 1996). Finally, the intrathyroidal 
cytokine expression profile in HT revealed expression of a mixed Th 1 and Th2 
response (Paschke et al., 1994; Ajjan et al., 1996). 
3. Experimental autoimmune thyroiditis 
3. 1 Animal models 
Animal models for thyroid disease have been developed to facilitate a better 
understanding induction, manipulation and modification of the pathogenic 
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process. Although it remains unclear as to what extent these animal models 
mimic the human disease, they provide an opportunity to easily intervene in the 
development and/or progression of EAT. 
A brief outline of four categories of animal models that are currently being 
used to study AITD is presented; In the spontaneous models including the pure-
bred obese strain (05) of chickens, BUF and BB rats and non-obese diabetes 
(NOD) mice, thyroiditis develops without the need for manipulation of the 
immune system or immunization (Bigazzi, 1993). In the second category 
involving mice, experimental autoimmune thyroiditis (EAT) results following 
manipulation ofT-cell sub-sets: spontaneous thyroiditis was observed in mice 
following injection of syngeneic CD4+ C osJow T cells subsequent to 
thymectomy, irradiation (Tx-X) and depletion of their own T cells (Sugihara et 
al., 1988). The third model involves SCID mice. Grafting of human thyroid 
tissue and infusion of peripheral blood mononuclear cells (PBMC) from patients 
with thyroid disease allowed further destruction of the grafted thyroid tissue in 
these SCID mice (Akasu et al., 1993). In the last model principally involving mice 
and rats, thyroiditis is induced after immunization with thyroid Ag in adjuvant 
or by adoptive transfer of thyroid Ag-specific lymphocytes. 
3. 1. 1 Spontaneous EAT 
Rats: BUF and BB rats show development of spontaneous thyroiditis. The 
disease incidence is low in young females but rises with age. The disease in 
females (as high as 48% incidence in ex-breeders) is characterized by the 
formation of germinal centers, presence of plasma cells and macrophages in their 
thyroid gland. Animals are highly susceptible to the development of severe 
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thyroiditis following s. c. injection of trypan blue, methylcholanthrene and 
neonatal thymectomy (Bigazzi and Rose, 1975; Silverman and Rose, 1974). 
BB rats develop spontaneous diabetes in addition to thyroiditis. Destruction 
of pancreatic beta cells occurs in about 30% of the rats of 60-120 days age. In 
older rats, however, the incidence is much higher up to 59% in the 8-10 month 
old group (Sternthal et aL, 1981). In contrast to diabetes, the incidence of 
lymphocytic thyroiditis varies in different sublines of this strain: subline NB 
showed 100% incidence while only 4.9% animals developed thyroiditis in subline 
BE (Rajatanavin et al., 1991). Treatments such as feeding of iodine-reduced diets 
and the administration of methimazole or T4 to suppress TSH, decrease the 
incidence of thyroiditis but not of diabetes in the BB rats. It was therefore, 
suggested that autoimmune processes underlying these diseases might be 
different. 
OS Chicken: Originally established by Cole in 1966 at a breeding center 
where the disease incidence was only 1% in the female birds, OS chickens were 
selectively bred over the years. Spontaneous autoimmune thyroiditis that 
develops in OS chicken resembles Hashimoto's thyroiditis in clinical, 
endocrinological, histopathological and immunological aspects (Wick et al., 
1982): (1) germinal centers develop in chicken of age 6-8 weeks and replace the 
glandular tissue leading to fibrosis of the thyroids, and (2) the presence of 
immune complex deposits formed by autologous C3, auto-Ab and Tg in the 
lamina propria of thyroid gland, have particularly enhanced the relevance of this 
model to study the human disease. Although the etiology of the spontaneous 
thyroiditis in OS chicken remains far from clear, three different groups of genes 
have been considered to exert control on the disease process. They include an 
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essential but yet unidentified autosomal recessive "disease susceptibility" gene, 
the modulating genes responsible forT-cell and macrophage hyperactivity, and 
altered iodine metabolism in the thyroid gland (Wicket al., 1989). Molecular 
mimicry by an endogenous virus present in the thyroid glands was hypothesized 
as a possible mechanism leading to thyroid autoimmunity in OS chickens (Wick 
et al., 1985), however, further evidence is lacking. 
NOD mice: Auto-antibodies to thyroid membrane antigens and thyroiditis are 
observed in these mice (Bernard et al., 1992). The incidence of thyroiditis is age 
but not sex-dependent and is prevalent in both diabetic as well as non diabetic 
animals. 
SCID mice: In an effort to study the behavior of HT or GD and PBMC, 
Volpe and co-workers developed a new model using SCID mice (Akasu et al., 
1993). SCID mice injected i. p. with PBMC and xenografted into their groins 
with thyroid tissue from HT patients were monitored for up to 6 weeks. The 
presence of both HTg- and TPO-reactive Ab and histologically worsening of the 
xenografts was noted in these mice suggesting that activation of the autoreactive 
lymphocytes continued to occur in these mice. 
3. 1. 2 Induced EAT 
In 1956, pioneering studies by Witebsky and Rose on experimental 
induction of autoimmune thyroiditis provided a great impetus to advance the 
field in this area. Their studies not only showed the involvement of thyroidal Ag 
in thyroid autoimmunity but also documented a methodology for induction of 
thyroiditis in rabbits by immunizing them with homogenate from syngeneic 
glands and CFA (Witebsky and Rose, 1956; Rose and Witebsky, 1956). Later, 
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thyroiditis was induced in various animal species: dogs (Terplan et al., 1960), rats 
(Jones and Roitt, 1961), guinea pigs (McMaster et al., 1961), monkeys (Kite et al., 
1966) and mice (Rose et al., 1971). 
Over the last four decades, Tg-induced EAT provided a great deal of 
knowledge about the genetics of susceptibility to, and immunoregulation of the 
thyroid disease, and the nature of the host immune cells participating in the 
thyroid autoimmunity. Recently, 9mer Tg-peptides in CFA have been found to 
induce EAT allowing a reductionist approach in further studies of the disease 
(Carayanniotis and Rao, 1997). It is noteworthy, that EAT resembles closely the 
autoimmune characteristics of HT but differs histologically in a few respects. For 
example, germinal centers, a hallmark of HT, are absent and no evidence exists 
for Hurthle (or Askanazy) cells or signs of fibrosis in the thyroid glands of 
animals undergoing EAT. In addition, it is unclear whether hypothyroidism 
follows thyroid infiltration in the animal studies and if so, whether or not it can 
lead to hyperthyroidism since HT patients in some instances develop GO 
eventually (Goolden et al., 1971; reviewed in Volpe, 1990). Since the present 
study focused on mouse EAT, an attempt has been made here to introduce to the 
reader some of the studies in this area that involved different approaches of EAT 
induction. 
Direct approaches of EAT i1Zductio1l: As mentioned earlier, investigations by 
Witebsky and Rose in 1956 opened the way to study human thyroiditis 
experimentally. Initially the thyroiditis induction protocol involved challenge of 
animals (rabbits) with a emulsified mixture of crude thyroid gland extract or 
purified fraction containing Tg and CFA (Witebsky and Rose, 1956; Rose and 
Witebsky, 1956). EAT was confirmed in these animals by the presence of auto-
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(MNC). Subsequent studies showed induction of thyroiditis in rabbits following 
immunization with heterologous or chemically altered homologous Tg (Weigle, 
1965). The immunopathogenic effects exerted by Tg were severe when a highly 
purified preparation was used to challenge rats (Roitt et al., 1965). These studies 
clearly established the basis for the subsequent era of characterizing Tg-induced 
EAT. 
The precise mechanism(s) whereby CFA mediates its adjuvanticity remains 
unknown, but its highly inflammatory nature and its Ag depot-forming effects 
have been considered to be crucial for its efficacy (Weigle et al., 1969; Yamanaka 
et al., 1992). Besides CFA, various other adjuvants including IFA (Rose et al., 
1965), LPS (Esquivel et al., 1977), muramyl dipeptide, a polyclonal B-cell 
activator (Rose et al., 1981), polyadenylic-polyuridylic acid complex (polyA:U) 
(Esquivel et al., 1978), and latex particles (Esquivel et al., 1977) have also been 
used. 
In general, both homologous and heterologous Tgs induce mouse EAT 
either directly or by adoptive transfer (Romball and Weigle, 1984; Charreire, 
1989; reviewed in Kong and Lewis, 1990; Carayanniotis and Rao, 1997). EAT 
induction by direct challenge of animals with Tg or Tg-peptides requires, besides 
having a genetically susceptible host, the optimization of various parameters 
such as Ag dose, route of Ag administration, immunization regimen, and the 
time window of thyroiditis assessment. 
Early epidemiological data suggested that excessive iodine intake 
precipitates autoimmune thyroid disease (reviewed in Burek and Bresler, 1990) 
and it was further supported by studies on OS chicken (Bagchi et al., 1985) and 
BB/W rats (Allen et al., 1986). The iodine content of Tg was noted to alter its 
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immunogenicity leading to loss of self-tolerance (Sundick et al., 1987) but the 
precise mechanism(s) of this phenomenon remains unclear. Raitt and co-workers 
have noted that poorly iodinated Tg is not a good inducer of EAT (Champion et 
al., 1987). Further, they have shown that the HTg-peptide (2549-2570), one of the 
four conserved sites of T4 synthesis on HTg, is recognized by mouse T cells that 
adoptively transfer EAT to syngeneic recipients (Champion et al., 1991). This 
supports the notion that iodinated regions of Tg constitute sites recognized by 
pathogenic T cells in EAT. However, recent studies (Kong et al., 1995) have not 
supported this notion. It was demonstrated that peptide (2549-2570) containing 
thyronine (To) that lacks iodine or T4 at 2553 are equally pathogenic. The 
peptides (1-12) and (2559-2570) encompassing other sites of T4 synthesis on Tg 
also do not induce EAT. The interpretation of these observations was that the 
immunogenicity of a hormonogenic epitope is influenced by its primary amino 
acid sequence and that iodinated Tg-determinants per se are not 
immunopathogenic (reviewed in Carayanniotis and Rao, 1997). The 
mechanism(s) by which (excessive) iodination of Tg may alter its 
immunogenicity leading to loss of self tolerance and thyroid pathology remains 
to be explored. 
Another approach followed in our laboratory to induce EAT has been to 
immunize mice with conjugates of Tg and mouse class II MHC-specific mAb 
(Balasa and Carayanniotis, 1993a). While the adjuvant-free priming of mice with 
m.Ab-Tg conjugates has been successful in abrogating the self-tolerance to Tg, as 
evidenced by the host IgG-responses against Tg, this regimen failed to induce 
thyroiditis, thereby suggesting lack of induction and/ activation of subset(s) ofT 
cells with pathogenic effector function in EAT. 
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Finally, Okayasu and Hatakeyama (1984) were able to induce thyroid 
lesions in mice by implanting fresh syngeneic thyroids under the kidney capsule 
or in the peritoneal cavity of host mice followed by i. v. injection of LPS, a potent 
polyclonal B-cell activator. 
In most of the studies described above, EAT was induced by Tg (or peptides 
thereof), the most abundant antigen of thyroid gland. It is noteworthy, however, 
that trypsinized porcine TPO or its immunodominant peptide (a. a. 774-788) is 
shown to be capable of inducing thyroid pathology in mice (Kotani et al., 1990; 
Kotani et al., 1992). Since TPO represents an important target molecule for 
thyroid autoimmune responses in humans, further work is needed to 
characterize other relevant epitopes on TPO capable of mediating EAT. 
Indirect approaches of EAT induction: These include: 1) adoptive transfer of 
Ag-specific/sensitized lymphoid cells into naive normal healthy hosts and 2) 
perturbation of the available pool of host lymphoid cells by neonatal 
thymectomy, depletion of certain T-cell subset(s) by irradiation. 
In the mouse model several groups of workers documented thyroiditis 
induction following transfer, into syngeneic recipients, of lymph node cells 
(LNC) primed in vivo and boosted in vitro with Tg (Braley-Mullen, 1985; Simonet 
al., 1986); in vivo Tg-sensitized T cells further activated in vitro by con A, were 
also shown to transfer EAT (Okayasu, 1985). To date, the only study where 
adoptive transfer of clonal populations ofT cells was observed to induce thyroid 
pathology was carried out by Romball and Weigle (1987). It is clear from these 
studies that Tg-specific proliferating cells predominantly of CD4+ phenotype 
partidpate in the induction of EAT. Using a synthetic peptide approach, work 
from other laboratories (Champion et al., 1991; Kong et al., 1995) as well as ours 
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(Carayanniotis et al., 1994; present study see chapters 5 and 6) have shown that 
LNC specific for defined Tg T-cell determinants can mediate severe thyroiditis. 
When IL-2R or anti IFN-y-specific Abs were added to MTg-sensitized 
murine splenocytes cultured in the presence of MTg (i.e., in vitro boosting with 
Ag) and the splenocytes were subsequently transferred to syngeneic hosts, the 
recipients developed a severe form of thyroiditis called 'granulomatous' EAT 
(Braley-Mullen et aL, 1991; Stull et al., 1992) which, like the lymphocytic form, 
required the Tg-specific CD4+ T cells. 
Another method of EAT induction was developed via the manipulation of 
the T-cell subsets in Wistar rats. Following thymectomy and sublethal total body 
irradiation (200 rads x 5 times at 2 week intervals) (Tx-X} the animals developed 
thyroiditis and Tg-reactive Ab (Penhale et al., 1973). The interpretation given to 
these data was that self-reactive and pathogenic T cells were neither deleted nor 
rendered anergic in these Tx-X rats but pathology ensued after the loss of 
regulatory T cells as a result of the above treatment. In support of this concept, a 
subsequent study showed that lymphocytes from normal syngeneic rats when 
transferred into the Tx-X hosts suppressed EAT development (Penhale et al., 
1976). 
Following a somewhat different approach, Sugihara and co-workers have 
observed development of thyroiditis after adoptive transfer of CD5dull CD4+ T 
cells in !-cell-depleted mice (Sugihara et al., 1988). Immunohistochemically, both 
CD4 + and CD4- T cells were shown to be present in the thyroid lesions (Sugihara 
et al., 1989). In addition, co-injection of fractionated CD4+ cells containing CD4+ 
CD5low cells prevented thyroiditis in the recipients. These findings led to the 
conclusion that thyroid autoreactivity results from a subset of CD4 + T cells with 
---
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low expression of CDS. This subset is kept in check normally by the CD4 + T cells 
expressing higher levels of CDS. Autoimmune thyroiditis may result when the 
balance tilts in favor of the CD4+ cosiow subset (Sakaguchi and Sakaguchi, 
1994). 
3. 2 Immunogenetics 
The issue of what precipitates autoimmunity in some but not other 
individuals even within the same extended family continues to be an intriguing 
puzzle for medical researchers. The etiology of human autoimmune thyroiditis 
or of other autoimmune diseases including insulin-dependent diabetes mellitus, 
multiple sclerosis and rheumatoid arthritis etc., is considered to be multifactorial 
(Burek and Bresler, 1990). As mentioned earlier, HT was found to occur more 
frequently in HLA DR4- or DRS- positive individuals (Volpe, 1990). It is possible 
that the actual gene responsible might only be associated with these HLA genes 
by linkage disequilibrium. To date, gene(s) primarily responsible for the 
occurrence of thyroiditis have not been characterized. On the other hand, EAT 
studies have generated a wealth of information on how different H-2 loci can 
affect mouse susceptibility to the induced disease. 
3. 2. 1 MHC genes 
The early pioneering work of Vladutiu and Rose (1971) provided strong 
evidence associating EAT-susceptibility in mice with their MHC loci. EAT was 
induced in 33 different mouse strains of 11 different haplotypes using thyroid 
gland extract in CFA. Based on their susceptibility to thyroiditis development, 
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the mouse strains were classified as: high responders (H-2s, k, or q haplotypes), 
low responders (H-2b, d, g, i, or v haplotypes) and intermediate responders (H-2a, 
m, r or P haplotypes). Further, experiments using congenic strains (e.g. C3H.SW 
vs. C3H/HeJ) sharing the same background non-H-2 genes, but having different 
H-2 alleles (k or b) suggested that the susceptibility is linked to the H-2 
haplotype. The susceptibility to EAT was shown to be autosomally dominant as 
F1 animals, of crosses between high- and low- responders, were good responders 
(Vladutiu and Rose, 1971). 
Employing several intra-H-2 recombinant strains and MTg as inducing Ag, 
Tomazic et al., (1974) localized the immune response (Ir) -gene controlling the 
susceptibility to EAT to the K and/or I-A region of the H-2 complex. The first 
evidence that the I-A region of the H-2 complex was mainly responsible for 
susceptibility to the EAT induction by MTg, came from studies by Beisel et al., 
(1982) who found high responsiveness to MTg in both B10.A(4R) and BlO.MBR 
strains that are only identical at their I-Ak genes of their MHC. Several other 
studies (Okayasu et al., 1981; Salamero and Charreire, 1983; Braley-Mullen et al., 
1985; Okayasu, 1985; Simon et al., 1986) confirmed the importance of the I-A 
locus in susceptibility to MTg-induced responsiveness. 
The importance of the D region within the H-2 complex was shown by 
Kong and co-workers who used four sets of intra-H-2 recombinant strains with 
the same K-end alleles but different D-end alleles. Within mice of high responder 
haplotypes k and s, thyroiditis was significantly reduced in mice expressing d, b 
and q but not f alleles at the D-end. Among the mice of poor responder 
haplotypes d and b, the D-end effect could not be appreciated due to the already 
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low level EAT that occurred in these strains (Kong et al., 1979). It was concluded 
that EAT severity depends on the interactions between I-A/I-E and D-end alleles. 
The influence of K-region on EAT development was initially suggested by 
Maron and Cohen (1979) based on the finding that EAT developed significantly 
in B6.H-2ha (HZl) mice, a mutant strain of C57.BL (H-2h) that carries a point 
mutation in the H-2K locus, and expresses Kba instead of Kb. On the contrary, 
Beisel and colleagues found no effect on EAT -susceptibility in mice with H-2Kb 
mutations. It became evident that the mutations in the K-locus had no effect on 
EAT severity unless high responder alleles (Ak) were present in the I-A 
subregion (Beisel et al., 1982). From these studies came the following conclusions: 
the primary genes controlling susceptibility seem to be those present in the I-A 
region; D and possibly K loci might regulate effector cell functions determining 
the incidence and severity of EAT. 
In the above genetic studies Tg- or thyroid extract- had been used to induce 
EAT. It remained unclear, whether or not the pattern of EAT induction by 
individual Tg-peptides would be analogous to that induced by intact Tg. In our 
laboratory, an algorithmic approach was used to identify putative T-cell sites on 
rat Tg (mouse Tg sequence was not known at that time). Direct challenge with 
the 17mer peptide (2495-11)* in CFA induced thyroiditis in H-2k (BlO. BR, C3H) 
and H-2s (SJL) mice but not in H-2d (BALBI c) or H-2b (BlO) haplotypes. A 
* A C-terminal MTg a. a. sequence was recently reported (Kuppers et al., 1996), revealing 
complete identity at the sites corresponding to (2495-2511) and (2695-2713) sequences on RTg. 
The two RTg-peptides, reported previously as TgPl and TgP2 will be referred in this study as 
MTg(2495-11) and (2695-13). 
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peptide-specific IgG response was observed in all the strains except B10 mice 
(Chronopoulou and Carayanniotis, 1992). Thus interestingly, the observed 
genetic pattern of mouse susceptibility to EAT induced by the peptide was 
similar to that of Tg-induced EAT as described in earlier work (Vladutiu and 
Rose, 1971). Subsequent studies, using intra-H-2 recombinant mice, suggested 
that, Ek gene was necessary but not sufficient for EAT induction, as the 
concomitant expression of Kk or Ak genes was required (Chronopoulou and 
Carayanniotis, 1993). 
Using the same algorithmic approach a second pathogenic sequence (2695-
2713)* was identified within RTg (Carayanniotis et al., 1994) that was pathogenic 
only in mice of H-2s but not H-zb, k or d haplotypes. Thyroiditis was induced in 
SJL mice by both direct peptide challenge and adoptive transfer of peptide-
specific LNC. These data highlighted the fact that when pathogenic Tg-
determinants are tested in isolation, they may not necessarily follow the genetic 
pattern of Tg-induced EAT. The same data also confirmed that Tg-determinants 
do not need to be iodinated in order to induce EAT, in contrast to what was 
envisaged earlier by others (Champion et al., 1987; Champion et al., 1991; 
Hutchings et al., 1992). 
3. 2. 2 Non MHC-genes 
Due to their highly polymorphic nature and their central role in Ag 
presentation, the MHC genes have been studied extensively in autoimmunity 
both in human and in animal models. However, it is becoming increasingly dear 
* for explanation see foot -note on the previous page 
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that non-MHC genes contribute significantly towards the incidence of 
autoimmune diseases (Garchon and Bach, 1991). In EAT, it became evident that 
non-MHC genes play a role in susceptibility when H-2 congenic mice with 
different background genes showed significant differences in disease incidence 
and Ab titers (Beisel et al., 1982a). For example, when CS7B1/10 and C3H.SW 
mice (both H-2b) were compared!' the latter strain showed 20-60% higher 
incidence of thyroiditis and 1.6-5.8 log2 higher titer of Ab. It was suggested that 
the non-MHC genes of C3H background favored EAT development. In other 
studies using recombinant inbred strains a gene from the Igh locus was shown to 
influence the Ab response to Tg (reviewed in Kuppers et al., 1988). Recently, the 
magnitude of MTg-spedfic IgG2a response was linked to genes in or near the Igh 
locus (Kuppers et al., 1994). 
Similarly, work on the OS chicken model of spontaneous EAT suggested 
that besides MHC, two other loci might play important role in the disease 
process, influencing thymus development and/or creating a defect in the thyroid 
gland (reviewed in Kuppers et al., 1988). In addition, genes that control 
macrophage function and those that co-segregate with the altered glucocorticoid 
response were also hypothesized to be important in the OS chicken model of 
spontaneous thyroiditis (reviewed in Wicket al., 1989). 
3. 3 Host immune responses 
The mouse, due to its well characterized immune system and the 
availability of reagents to many of its lymphocyte markers, has provided a great 
deal of knowledge not only on the immunogenetic aspects of thyroiditis but also 
in assessing the role of different lymphocyte sub-sets in disease pathogenesis. 
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that MTg-specific helper T cells alone can initiate thyroiditis although host PBMC 
cells might become involved secondarily in the disease process. 
Another line of evidence in support of effector T-cell involvement in EAT 
came from studies by Kong and co-workers (reviewed in Kong and Lewis, 1990). 
Immunofluorescence studies on pooled intrathyroidal cells collected between 12-
21 days after challenge with MTg in CFA, showed an early predominance of Lyt-
1 +cells which was followed by an increase of Lyt-2+ cells resulting in ratios that 
were very much different from those in peripheral blood (Creemers et al., 1984). 
Flynn et al., (1989) attempted to delineate the contribution of CD4+ (previously, 
L3T4 +) and cos+ (previously, Lyt-2+) cells. Based on treatment of mice with 
anti-CD4 or anti-CD8 mAb prior to or following the transfer of cells, it was 
concluded that donor CD4+ cells were the primary effector cells mediating the 
thyroiditis transfer while both the cos+ and CD4 +cells influenced the severity 
of the disease. In a separate study, Stull et al., (1988) found that splenocytes from 
mice pretreated with anti-CD4 mAb did not proliferate in vitro to MTg nor 
transfer the disease to normal recipients. EAT was reduced in recipients of MTg-
activated splenocytes, if they had been injected with mAb before or after 14-19 
days following the cell transfer. These findings clearly emphasize the 
predominant role played by helper T cells in the effector phase of EAT 
development. Spontaneous models of EAT also suggested an essential 
involvement of a CD4+ (CDsdull) subset in the pathogenesis of thyroiditis 
(Sugihara et al., 1993). 
To date, few studies have documented the cytokine-profiles of lymphocytes 
with pathogenic effector function in EAT. Sughihara et al., (1995) demonstrated 
that a thyroid epithelial cell (TEC)-reactive, Cos+ line secreted IL-2, IFN-y, and 
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TNFa but not IL-4 and IL-5, thus resembLing a Thl-type cytokine profile. 
Further, indirect evidence such as: 1) treatment of mice with mAb against IFN-y 
reduced the Tg-Ab response and severity of thyroiditis in mice (Tang et al., 1993); 
and 2) oral feeding of Tg (a regimen known to elidt aT-cell subset with Th2-type 
cytokine profile) (Guimaraes, 1995; Guimaraes, 1996) protected mice from Tg-
induced EAT, support the notion that thyroiditis is mediated by Thl-type cells. 
3. 3. 2 8 cell response 
Although the role of T cells is established in EAT, the contribution of 
specific Ab is unclear. A good correlation exists between the incidence of 
thyroiditis and the detection of Tg (or TPO) specific Ab in human sera, but Ab 
presence alone is not suggestive of disease condition (Burek and Bresler, 1990). 
In EAT, the adoptive transfer of immune serum from Tg-challenged donors has 
resulted in mild disease in mice (Vladutiu and Rose, 1971a; Tomazic and Rose, 
1975) guinea pigs (Godal and karesen, 1967) and rabbits (Nakamura and Weigle, 
1969) but not in monkeys (Roitt and Doniach, 1958) and rats (Rose et al., 1973). 
These disparate findings about the role of Ab in EAT may reflect variations in the 
detection-methodology and perhaps, the immunological heterogeneity of the 
species. However, even in the mouse model, the failure by others to show EAT 
transfer by immune serum (Okayasu, 1985) or the lack of a good correlation 
between Ab titers and severity of thyroid lesions (Vladutiu and Rose, 1972; 
Esquivel et al., 1978) suggests a minor role (if any) for Ab in Tg-induced EAT. 
Expectedly, the serum of Tg-challenged mice contains Abs with a mixture of 
specificities (some are directed to pathogenic determinants while others are not), 
and conceivably, there is a qualitative variation in the nature of epitopes targeted 
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by the immune responses and their influence on EAT development. Recent 
attempts to obtain high local auto-Ab concentration by perfusion of thyroids in 
situ (via the superior thyroid artery) with sera containing high titers of anti-Tg 
Ab (but not sera lacking anti-Tg Ab) led to induction of thyroiditis in rabbits 
(Inoue et al., 1993a). Further studies are necessary to confirm these findings in 
other models. 
3. 3. 3 Other immune mediators 
In a recent study the importance of late complement components was 
assessed in rabbits challenged with homologous thyroid extract (Inoue et al., 
1993). Rabbits deficient in the sixth complement component (C6-D) exhibited 
less disease severity than normal controls. This effect was reversed by 
administering serum from normal rabbits, suggesting a role for C6 in EAT. 
Among the immune mediators, recombinant IFN-y (riFN-y) has been assessed 
directly for its ability to mediate EAT (Remy et al., 1987). Mice injected 
intrathyroidally with one unit of riFN-y developed anti-Tg Ab in 70% of the 
animals and thyroiditis in all of them. It was suggested by Charreire and 
colleagues that lymphocyte infiltration of the thyroid could be initiated with the 
local production of IFN-y by the resident lymphocytes of the thyroid gland 
following an unknown initial trigger in the disease cascade. The same group 
recently investigated the role of human riL-10 and IL-4 on MTg-induced EAT. 
Compared to the control group, riL-10-treated mice exhibited reduced 
proliferative and cytotoxic responses of splenocytes and a much less severe EAT. 
The protective effects of!L-10 were explained to be due to the activation induced 
cell death ofT lymphocytes (Mignon-Godefroy et al., 1995a). Lastly, in a study 
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comparing the in vitro effects of murine riL-4 and human riL-10 on MTg-
sensitized spleen cells prior to their adoptive transfer into syngeneic naive mice, 
IL-10- but not IL-4-treated cells showed decreased proliferative responses and 
mediated less severe thyroiditis (Mignon-Godefroy et al., 1995), findings 
consistent with a protective role ofiL-10 in EAT. 
4. T-cell determinants in murine EAT 
In the mid-1980s it became dear that priming of mice with homologous 
MTg elicited T cells that proliferated in vitro against the heterologous HTg 
(Simonet al., 1985). Conversely, T cells from HTg-immunized mice could be 
activated and expanded in vitro with MTg to transfer thyroiditis or show 
cytotoxicity to thyroid monolayers (Kong et al., 1986). Parallel studies showed 
that pathogenic T-celllines or clones specific for Mrg (Romball and Weigle, 1987) 
or T -cell hybridomas (Champion et al., 1987) recognize Tg-determinants 
conserved across Tg of other species. However, the location of these 
determinants on the MTg was unknown until recently partly because the MTg 
sequence was not known and partly due to the large size of Tg molecule. 
The prevailing notion in the field is that Tg harbors a limited number ofT-
cell determinants since Tg-induced EAT is controlled by the I-A locus as 
discussed earlier (see section 3. 2. 1). Processing of Tg by APC leads to 
presentation of the "dominant" determinants with thyroiditogenic properties. 
Dominant determinants meet two criteria: 1) following challenge with whole 
protein, specific T-cell responses can be demonstrated against these determinants 
ill vitro , and 2) conversely, T-cell responses induced in vivo against these 
determinants can be recalled in vitro with the whole protein Ag. On the other 
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hand, some determinants can induce specific T-cell responses that can be 
demonstrated i1I vitro against themselves but not the whole protein Ag that they 
are part of; and in turn, priming with the whole Ag fails to induce T -cell 
responses against those determinants. Such determinants are said to be 'cryptic' 
(reviewed in Sercarz et al., 1993). Further, these cryptic determinants can be 
divided into facultative or absolute depending on whether the induced T cells 
will respond to large doses of native Ag or not. 
4. 1 Epitope mapping 
4. 1. 1 Thyroglobulin 
Diverse strategies were used to identify pathogenic Tg epitopes. Raitt and 
co-workers first demonstrated a critical role for iodination in T-cell recognition of 
Tg employing two clonotypically distinct HTg-reactive murine T-cell hybrids 
ADA2 and CH9. Poorly iodinated HTg or MTg purified from aminotriazole (an 
inhibitor of TPO)-treated mice failed to activate the T-cell hybrids (Champion et 
al., 1987). Later, using synthetic T4-containing peptides representing the four 
major hormonogenic sites in Tg, they identified a 9mer epitope (2551-2560) 
containing T4 at position 2553 as the T-cell determinant seen by those hybrids 
(Champion et. 1991). And in a subsequent study, HTg(2549-2560)- primed LNC 
adoptively transferred EAT to naive syngeneic recipient CBA mice, following in 
vitro activation with the peptide (Hutchings et al., 1992). While these 
experiments clearly provided evidence that T4-containing Tg-epitopes can induce 
T cells with a pathogenic role in EAT, it was not clear whether T-cell activation 
depended on the presence of iodine within T4 or simply required the two phenyl-
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ring side chain of T4. A study by Dawe et al., (1996) addressed this issue. When 
two analog peptides containing T4 or To (that lacks iodine) were assessed for 
their capacity to activate the hybrids ADA2 and CH9 only the former was 
stimulatory suggesting the importance of the four iodine atoms for the 
antigenicity of HTg(2549-2560). 
A recent study by Kong and co_-:-workers (1995) reexamined whether or not 
iodine is important in T-cell recognition and EAT induction. They tested three 
HTg 12mer peptides (1-12, 2549-2560 and 2559-2570), carrying T4 at the primary 
hormonogenic sites 5, 2553 and 2567. Peptides carrying To were used as controls. 
It was found that both T4 (2553)- and To (2553)- containing peptides were 
immunogenic and activated splenocytes from CBA mice primed either with MTg 
or the respective peptide, to adoptively transfer thyroiditis to syngeneic hosts. 
This suggested that the presence of iodine was not necessary for pathogenicity. 
When the T4 (5)- and T4 (2567)- containing peptides were tested similarly, both 
exhibited poor immunogenicity and antigenicity. These findings demonstrate 
that the presence of T4 within a hormonogenic site is not sufficient to impart 
immunogenic properties. Interestingly, LNC from mice primed with the T4 
(2553)-containing epitope could neither be cross-stimulated by the To (2553)-
containing analog, as evidenced by lack of a proliferative response nor EAT 
transfer. This suggested that iodine atoms sufficiently modify the peptide-MHC 
complex and induce a distinct subset of pathogenic T cells that exclusively 
recognize the T4 (2553)-containing epitope. This result is consistent with the 
finding (Dawe et al., 1996) that T4 (2553)-containing peptide-reactive hybrids 
cannot be activated by the To (2553)-containing analog. 
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A different approach followed by Charreire and co-workers led to the 
characterization of a pathogenic 40mer Tg-peptide (Texier et al., 1992). They 
used a class !-restricted cytotoxic T-cell hybrid that lysed syngeneic CBA 
macrophages pulsed with tryptic porcine Tg fragments of< 10 kD. Subsequent 
purification and sequencing of the selected peptide revealed partial homology 
with the HTg and a 40mer HTg (1672-1711) peptide representing the region of 
homology was synthesized. Challenge of CBA/J mice with this peptide led to 
EAT in 4 out of 5 hosts (Texier et al., 1992). However, it remained unclear if 
thyroiditis developed because of a response to the class !-restricted determinant 
recognized by the hybridoma or because of a response to another unknown 
epitope within the 40mer sequence. 
A third approach was based on earlier findings by McLachlan and Rapoport 
(1989) that HTg and human thyroid peroxidase (hTPO) share B-cell epitopes and 
it was hypothesized that they may also share T-cell epitopes. Hoshioka and co-
workers (1993) identified two 14mer peptides HTg(2730-43) and hTP0(118-131) 
which had 5 identical consecutive a. a. in common and elicited weakly cross-
reactive T-cell responses. Proliferative assays strongly suggested that the HTg 
peptide contained an immunodominant T-cell epitope but direct challenge of 
mice with this peptide, or adoptive transfer of peptide-specific spleen cells did 
not induce thyroid pathology. Extensive thyroiditis was observed only by 
adoptive transfer of cells that were primed in vivo with MTg and boosted in vitro 
with HTg(2730-43). The reasons for these discrepancies were not discussed. 
In our laboratory, the search for putative T-cell epitopes made use of 
computerized algorithms (Margalit et al., 1987; Rothbard and Taylor, 1988) to 
scan the RTg sequence (the MTg sequence was unknown). A 17mer 
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nondominant peptide (2495-2511) was identified and shown to induce EAT in 
different mouse strains with a pattern similar to that of Tg-induced EAT 
(Chronopoulou and Carayanniotis, 1992). Subsequently, attempts were made to 
identify the l\.1HC loci controlling the peptide-induced disease. Based on the EAT 
susceptibility of intra-H-2 recombinant BlO.BR strains following peptide 
challenge, it was concluded that the I-E gene was necessary for disease induction 
but insufficient since the Kk and/ or ok end genes were also required for the 
thyroiditis to occur (Chronopoulou and Carayanniotis, 1993). It remained, 
however, unclear whether the 17mer peptide harbored one or more T-cell 
determinants and what their 1\liHC-restriction was. Also, these studies could not 
explain how the peptide-induced EAT is influenced by the I-E locus in H-2k 
haplotype mice since the same peptide induced EAT in H-2s haplotype mice that 
lack functional I-E molecules. 
Via the same algorithmic approach a second peptide on RTg with 
coordinates (2695-2713) was identified and tested for EAT induction in different 
mouse strains (Carayanniotis et al., 1994). The peptide elicited EAT in SJL (H-2S) 
but not C3H or B10.BR (H-2k), BALB/c (H-2d) and BlO (H-2b) mice. These 
findings suggested a new genetic pattern of susceptibility to EAT (different from 
that of Tg-induced EAT) provided the first evidence of an AS-restricted 
pathogenic Tg-determinant. 
In the latter study (Carayanniotis et al., 1994), it was also shown that 
MTg(2695-2713) is identical with its counterpart within the HTg sequence at 
fifteen of the nineteen positions (79% homology) and carries three amino acid 
substitutions at positions 2703 (Q > 5), 2704 (T > 5), 2707 (D > T) and one 
insertion (5) at position 2708. The new questions generated from these data were: 
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(1) Is the HTg(2695-2713) immunogenic or pathogenic in SJL mice ?; (2) Are the 
human and mouse homologs mutually cross-reactive at the T- and/or B- cell 
level ? Answers to these questions (see Chapter 6) would illuminate what 
effect(s) (if any) these above a. a. substitutions have on the immunopathogenicity 
of the HTg-peptide, and thus, provide clues as to why some Tg (for example 
bovine Tg) fail to induce thyroiditis despite being immunogenic in mice (Romball 
and Weigle, 1984). 
In summary, data from various laboratories support the notion that Tg T-
cell determinants do not need to be either iodinated or immunodominant to be 
able to induce thyroiditis. The role of cryptic epitopes in autoimmunity remains 
unclear but increasing evidence suggests that a large number of cryptic self-
determinants can be generated as a result of altered Ag processing by APC 
(Salemi et al., 1995; Lanzavecchia, 1995). In addition, the immune response can 
spread to the less dominant or cryptic self determinants (intra-molecular 
spreading) leading to a state of self-sustained chronically disregulated 
autoreactivity (Lehmann et al., 1993). 
4. 1. 2 Thyroid peroxidase 
Relatively little is known about T-cell determinants of TPO. Kotani et al., 
(1990) induced EAT in C57BL/6 (H-2b) mice following immunization with 
immunoaffinity-purified porcine TPO (pTPO) in CFA or by adoptive transfer of a 
specific T-cellline. In a subsequent study, following proteolytic cleavage with 
cyanogen bromide, purification by reverse phase chromatography and analysis 
of synthetic peptides based on comparison with eDNA sequence of pTPO, Kotani 
and co-workers further identified an immunodominant T-cell determinant (774-
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788). Direct challenge of mice with this 15mer peptide induced thyroiditis in 66-
75% of the mice. Also pTPO-reactive Ab was observed in these mice. 
5. T -cell receptor variability in autoimmune thyroid disease 
Since T cells recognize MHC-bound peptide determinants via their TCR, 
studies in recent years have focused on the diversity of TCR on autoreactive T 
cells. The assumption has been that if the TCR of autoreactive cells are of limited 
heterogeneity a therapeutic approach can be developed to eliminate those cells 
before the onset of autoimmunity or to reverse the pathogenic process in 
already affected subjects. Two approaches were used in animal studies to test 
this concept: the first relied on the in vivo administration of mAb specific for 
appropriate TCR V~ families to eliminate autoreactive cells expressing these 
families (Zaller et al., 1990); the second depended on vaccinating animals with 
glutaraldehyde-fixed autoreactive T cells to induce anti-clonotypic immunity 
leading to induction of regulatory cells against the injected clones (Ben-Nun et 
al., 1981). The practicality of TCR-based immunotherapy in human autoimmune 
disease has been questioned because of the extensive polymorphism of HLA 
genes and high variability in TCR V-gene usage among patients (Kono and 
Theofilopoulos, 1993). 
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5. 1 In human studies 
Two methods were used to study TCR variability in human AlTO. The first 
method relied on the observation that after digestion with restriction enzymes, 
DNA from differentiated mature T cells gives rise to a clonotypic pattern when 
probed by TCR-~ gene probe with a Southern blot. DNA from T cells of a 
monoclonal population will yield a new uniform-sized fragment in a pattern that 
can be distinguished from that of the germ line DNA. On the other hand, a 
similar analysis using DNA from T cells of a polyclonal population will reveal a 
pattern of multiple bands of varying length due to the nucleotide differences in 
the rearranged segments encoding V~, D and J regions of TCR. Therefore, the 
higher the degree of polyclonality of the sample T cells, the greater will be the 
number of differences in comparison to the host germline DNA. 
The second approach was based on the amplification of sample T-cell eDNA 
by the polymerase chain reaction (PCR) method. The amplification is selective 
since it is achieved by using primers each specific for a different TCR-V~ gene 
family and the sample donality is, therefore, inversely proportional to the 
number of primers able to amplify the sample DNA. Once amplified using a 
given V~ family specific primer, the product represents DNA from all the T cells 
present in sample that were using the specific V~ genes regardless of their 
donality and fine Ag specificity. 
Kaulfersch and co-workers (1988) determined the clonality of ITL following 
the first described approach namely, TCR gene rearrangement analysis. On the 
basis of Southern blots of EcoRl and BamHl digests of circulating and 
infiltrating lymphocytes with a radiolabeled TCR probe, these workers suggested 
that the ITL were polyclonal in nature. Davies et. al., (1991) used the PCR 
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approach and showed that, ITL from patients with autoimmune thyroid disease 
had expressed restricted Va gene usage although the pattern of the Va chain 
usage varied from patient to patient. Based on the inconsistent restriction in the 
TCRa genes with T cells from each patient showing a different pattern of 
expression, it was hypothesized that cells with certain TCR-Va genes might show 
preferential homing. In a second study, Davies and co-workers also observed 
that ITL obtained from six patients with AITD, expressed a widespread usage of 
V~- but not Va- family genes (Davies et al., 1992). The mean utilization of the 18 
Va and 19 V~ gene families (that they were tested for), were 4.7 (range = 2 to 8) 
and 14.4 (range = 8 to 18) respectively. Their interpretation was that, the 
observed selective utilization of Va genes by T cells might result from some 
preferential recruitment that is antigen-unrelated, probably analogous to V~­
based selection by superantigens operative at the target organ level. Further 
independent work is needed to support this hypothesis. Lastly, Davies and co-
workers observed comparatively less TCR diversity in biopsied thyroid 
specimens from GD than those from HT (Davies et al., 1993). While confirming 
the previous observations, the study further suggested that GD patients early in 
the disease may have ITL with more restricted V-gene usage. 
In contrast to the above findings from Davies group, Mcintosh et al., (1993a) 
observed noVa gene restriction in GD, since PCR amplification with 10-15 Va 
families occurred in all of the twelve cases examined. No significant difference 
was found between the PCR amplification pattern of TCR with lymphocytes 
derived from peripheral blood of normal controls vs. patients or with the intra-
thyroidal lymphocytes obtained from patients with GD or toxic nodular goiter. 
In a second study by Mcintosh and co-workers, eDNA from lymphocytes from 
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peripheral blood or thyroid tissue were examined for TCR-Va heterogeneity. In 
comparison to peripheral blood samples ITL showed no less heterogeneity, 
suggesting the polyclonal nature of these T cells (Mcintosh et al., 1993). 
In a recent study that examined the TCR V-gene usage in seven GD patients 
(treated with carbim.azole), a widespread use of 12-18 V-gene families by the ITL 
was noted (Caso-Pelaez et al., 1994}. Peciusion·of one thyroid gland to avoid 
blood contamination made no difference in the results obtained. 
The apparently conflicting evidence on the issue of TCR variability of AITD 
may be related to the differences in the etiology of AITD, determinant selection 
effects by HLA gene products, variation in the detection methodologies or the 
time of tissue sampling. To resolve the issue of TCR variability in AITD more 
studies are necessary. Since HLA is known to have profound effects on the TCR 
repertoire, comparison of V~-profiles between HLA-matched individuals with 
AITD must be undertaken. Even then it is difficult to interpret data on TCR 
variability in the absence of knowledge of TCR ligand and the restricting HLA 
molecule. Significant variations in the autoreactive TCR V -gene usage are likely 
to occur depending on whether class I or II MHC molecules present pathogenic 
determinants to such cells. 
5. 2 In mouse EAT 
In NOD mice spontaneously developing EAT, predominant expression of 
up to 3 TCR-V~ gene products among ITL was interpreted by Matsuoka et al., 
(1993) to be consistent with a restricted TCR use. Sequencing of the amplified 
VDJ region further suggested that at least one of the overexpressed V~ gene 
families was clonally expanded but the expanded V~ family was different in each 
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mouse. Even within the same V~ family products, VDJ region homology at the 
nucleotide or amino acid level was lacking. The interpretation given to these 
data was that the choice of the TCR V(3 rather than D or J segment determined 
the process of thyroid infiltration. On the other hand, in mice developing 
spontaneous EAT following elimination of regulatory T -cell subsets, Sugihara et 
al., (1993) observed use of V~ 2, 4, 8.3, 14 and an undefined V~ by m. Out of 
these, T g-reactive T cells expressing V~ 2, 8.3 and the undefined V~ receptors 
were found to adoptively transfer EAT, while V~ 4-expressing cells, reactive to 
some uncharacterized TEC-associated antigen, did not transfer EAT. 
In Tg-induced thyroiditis in CBA/J mice, Matsuoka et al., (1994) stated that 
there was a biased, oligoclonal T-cell expansion because 10 out of 17 V~ families 
( 1, 2, 4, 5, 6, 7, 8, 11, 13 and 16) were expressed by the intrathyroidal T cells 
analyzed 28 d post immunization. Tg-specific T-celllines were also reported as 
biased because they expressed 7/17 families (1, 2, 4, 8, 11, 21 and 16). The 
authors suggested that the TCR-V~ influenced lymphocyte homing to the 
thyroid. In apparent contrast to these findings, Braley-Mullen and co-workers 
(McMurray et al., 1996) recently observed use of multiple TCR vp families 
including vp 1, 2, 4, 6, 8, 11, 13 and 14 by intra thyroidal MNC. Using RT -PCR, 
they have observed no differences in vp T-cell repertoires in thyroids with 
lymphocytic vs. granulomatous EAT. 
It is clear that in both spontaneous and Tg-induced models of EAT 
described above there is considerable heterogeneity in the Vj3-gene usage by Tg-
specific T cells in the periphery or ITL. The apparently contradictory 
interpretations given to these data stem partly from the number of families used 
to define ' diverse' vs. ' restricted' TCR usage. It is difficult to interpret data on 
37 
TCR variability purely on the basis of their thyroidal origin or specificity for Tg 
since the fine Ag specificity of such cells is not known. Diverse epitopes may be 
recognized by T cells with diverse TCRs even when the same MHC molecule is 
involved in Ag presentation. In EAT, no TCR V-gene families had been assigned 
toT-cell clones that recognize defined pathogenic Tg determinants prior to the 
present study (see Chapter 5). As mentioned earlier, the knowledge on TCR 
gene use among cells recognizing a thyroiditogenic determinant would be useful 
to design an approach for elimination of such cells. 
6. Molecular mimicry and AITD 
Infection by microorganisms, especially viruses, has long been suspected to 
predispose certain individuals for autoimmunity. One of the mechanisms put 
forth to explain how microbes cause autoimmunity is 'molecular mimicry'. 
Initially proposed by Damien (1964) to denote sharing of antigenic determinants 
between a host and parasite, molecular mimicry as a concept was developed by 
Fujinami et al., (1983) to explain the induction of autoimmune responses. They 
suggested that, Ags shared between parasite and host can be sufficiently similar 
to cross-react immunologically, but bear enough dissimilarity to allow 
breakdown of tolerance and generation of an autoimmune response. Expectedly, 
when the self epitope is part of an important host protein such as an enzyme or 
hormone receptor, a dysfunction may result during the immune response against 
the foreign microbe. They also suggested that the microbe's presence is not 
necessary for the autoimmune attack to progress or perpetuate. 
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6. 1 Molecular mimicry involving thyroidal antigens 
Little evidence exists in the literature to clearly substantiate the molecular 
mimicry phenomenon in AITD. Although the thyroidal antigens are known in 
AITD, knowledge of a. a. sequence of thyroiditogenic peptides is necessary in 
order to search for sequences from microbial proteins with potential for EAT 
induction via molecular mimicry. 
In human studies several examples have suggested an association between 
viral infections or anti-viral immu.."l.e responses and thyroid disease (Tomer and 
Davies, 1995). For example, subacute thyroiditis was found to occur in epidemic 
proportions (Eylan et al., 1957; deBruin et al., 1990) in summers coinciding with 
the distribution of enteroviruses. Mumps (Eylan et al., 1957) and Epstein-Barr 
(Coyle et al., 1989) viruses were implicated in the causation of subacute 
thyroiditis. In an extensive study (Volpe, et al., 1967), serum Abs from patients 
with subacute thyroiditis reacted against a number of viruses including 
influenza, coxsackie, mumps, ECHO and adenoviruses were observed. In 
children with rubella syndrome, Abs reactive with TPO or Tg were 
demonstrated in 34% of the patients (Ginsberg-Fellner et al., 1985). Likewise, 20% 
of the patients (women) with chronic hepatitis C infection showed significant 
levels of thyroid autoantibodies (Tran et al., 1993). 
These studies are based on data from serological cross-reactivity with 
viruses and it is difficult to relate the occurrence of the virus-reactive Abs with 
the events in the development of thyroid disease because of the presence of 
polyreactive Abs. Moreover, no particular virus has been clearly shown to be 
associated with etiopathogenesis of AITD in humans. 
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A. a. sequence homology between a host protein and a microbial Ag may 
not necessarily indicate that an autoimmune response will develop upon 
infection with the appropriate microorganism. To date there is no strong 
evidence to support molecular mimicry as an underlying cause of thyroid 
autoimmunity. In the past, several studies suggested an association between GD 
and Y ersinia enterocolitica infection. Based on the higher frequency of Yersinia 
-reactive Ab in GD patients (Shenkman et al., 1976) and the demonstration of a 
TSH-binding site on Yersinia membranes (Weiss et al., 1983), it was hypothesized 
that GD might result due to molecular mimicry by Yersinia infection. This was 
further supported by Wenzel et al., (1988), who showed that GD patients had 
Abs reactive with plasmid-encoded Yersinia Ag. However, the role of Yersinia in 
precipitating AITD in humans is controversial (Volpe, 1990). A recent study by 
Arscott and co-workers examined reactivity of sera from GO and HT patients or 
healthy controls and found no unique pattern of serological reactivity with 
Yersinia Ag (Arscott et al., 1992). Further evidence against the role of Yersinia in 
the pathogenesis of AITD comes from the fact that patients with thyroid disease 
show clinically no evidence of Yersinia infection even when they have Abs 
reactive with the organism (Ingbar et al., 1987) and, from the observation by Wolf 
and co-workers (1988) that patients recovering from Y. enterocolitica infections 
show no signs of thyroid dysfunction despite having Abs with "Graves' like 
activity" and reactive with thyroid epithelium. In addition, immunization of rats 
with Yersinia protein elicited anti-TSH receptor Abs but completely failed to yield 
any evidence of thyroid disease (reviewed in Volpe, 1990). 
In EAT, Srinivasappa et al., (1988) documented that mice infected with 
reovirus type 1 developed anti-Tg and anti-TPO Abs and lymphocytic infiltration 
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of their thyroids. These mice, however, showed no alteration in thyroid function. 
In contrast, a decrease in the Tg mRNA and circulating Tg hormones was 
observed in mice infected with lymphocytic choriomeningitis virus (Klavinski et 
al., 1988). Interestingly, no autoantibodies to Tg were observed, and despite the 
viral persistence, no signs of morphological changes or inflammation were 
observed in the thyroids. 
Finally, the only study showing structural homology between viruses and 
TPO was by Dyrberg (1989). Within the human TPO sequence five stretches each 
of eight to ten residues were found to bear homology with proteins from three 
different viruses namely, adenovirus (types 2 or 5), hepatitis B and 
papillomavirus. Despite their impressive homology with TPO, none of the viral 
sequences have been investigated further. In the present study an attempt has 
been made to investigate the relevance of a sequence similarity between a 
pathogenic Tg T -cell determinant and murine adenovirus type 1 ElB protein 
(see Chapter 7). 
CHAPTER 2 
THESIS PROPOSAL AND OBJECfiVES 
For almost three decades murine EAT, as a model for HT, has generated 
valuable data leading to a greater understanding of the immunogenetics, 
pathology and immunoregulation of thyroiditis. This information has played a 
major role in developing our current understanding of HT. It is well established 
that immu..rtization of genetically susceptible mice with MTg in adjuvant (CFA) 
induces thyroiditis and is influenced by the host MHC class II molecules. 
However, most thyroiditogenic epitopes in Tg or other thyroidal Ags still remain 
unknown. Previous studies in our laboratory have shown that the 17mer 
MTg(2495-11) peptide induces thyroiditis in mice of k and s haplotypes, while a 
second peptide MTg(2695-13) mediates thyroid pathology only in mice of s 
haplotype. Therefore, it was felt important to accurately map pathogenic T -cell 
epitopes within these sequences and further investigate the profile ofT cells that 
recognize them. 
Objectives: 
1) To determine which T-cell determinants within the pathogenic MTg(2495-11) 
peptide are responsible for EAT induction in mice of two different haplotypes 
2) To examine the lymphokine profile and TCR V~-gene usage among cells 
specific for a minimal Tg-epitope within MTg(2495-11) capable of inducing EAT 
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3) To map pathogenic T-cell epitope(s) within MTg{2695-13) and further 
examine if the limited a. a. variations present in the homologous HTg sequence 
would affect its immunopathogenicity 
4) To test the concept of molecular mimicry in EAT, working with a viral peptide 
of murine adenovirus type 1 ElB-protein. s£owing high homology with 
MTg(2695-13). 
CHAPTER 3 
MATERIALS AND METHODS 
3. 1 ANIMALS AND ANTIGENS 
Female C3H/HeJ, CBA/J, BlO.BR/SgSnJ, Bl0.A(2R), Bl0.A(4R), BlO.A(SR) 
and SJL/J mice of age 6-10 weeks, were obtained from the Jackson Laboratories, 
Bar Harbor, ME, USA and used for immunizations at 6-10 weeks of age. 
Frozen thyroids from Sprague-Dawley rats (Bioproducts for Science, 
Indianapolis, IN, USA) or frozen normal thyroid tissue from patients undergoing 
thyroidectomy due to thyroid carcinoma (kindly provided by Dr. A. Kwan) were 
used for the purification of rat and human Tg respectively, by gel filtration on 
Sepharose CL-48 columns (Pharmacia, Baie d'Urfe, Quebec, Canada) as 
described in section 3. 1. 1. Ovalbumin was purchased from Sigma (St. Louis. 
MO, USA). Tuberculin purified protein derivative (PPD, Seruminstitut, 
Copenhagen, Denmark) was purchased from Cedarlane (Ontario, Canada). 
The peptides were synthesized at > 75% purity at the Alberta Peptide 
Institute on an Applied Biosystems (Foster City, CA) 430 A synthesizer or at the 
Medical Center Protein Chemistry Facility of the University of Pennsylvania 
using a general procedure for solid-phase synthesis outlined by Erickson and 
Merrifield (1976) with modifications by Hodges et al., (1988). Briefly, the 
procedure included hydrogen fluoride cleavage of peptide resin at -5 °C for one 
hour in hydrogen fluoride: anisole: dimethyl sulfoxide (DMSO):p-thiocresol: 
peptide resin (10 ml: 1 ml: 0.5 ml: 0.2 ml : 1 g). Peptide purity was assessed by 
HPLC and mass spectroscopic analysis. MTg(2495-2511) (acetyl-
GLINRAKAVKQFEESQG-amide, termed previously as TgPl) and truncated 
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peptides thereof, similarly carrying an acetyl group at their N-terminal and an 
amide group at their C-terminal (synthesized at the Medial Center Protein 
Chemistry Facility of the University of Pennsylvania), MTg(2695-2713) (acetyl-
CSWSKYIQTLKDADGAK-amide, termed previously as TgP2) as well as the 
three overlapping 12mer peptides representing its core, N- and C-terminal 
regions were completely soluble in aqueous media where as HTg(2695-06) was 
dissolved (10 mg/ml) in DMSO. For descriptive purposes, amino acid positions 
within MTg(2495-2511) are identified by the HTg sequence numbering, since the 
complete MTg sequence is not known. The murine adenovirus type 1 E1B(a. a. 
368-91) and (368-78) peptides were synthesized at Alberta Peptide Institute 
whereas (368-77) peptide was synthesized by Synpep (Dublin, CA, USA). 
3. 1. 1 Thyroglobulin purification 
Frozen thyroid glands of outbred ICR mice or Sprague-Dawley rats were 
homogenized in phosphate buffer (pH 7.0). The clear homogenate was 
centrifuged thrice at 16,000 x g and the supernatant was passed through 
Sepharose CL-4B (Pharmacia, Quebec, Canada). Fractions corresponding to the 
second peak, previously shown during calibration of the column to overlap with 
BTg elution, were pooled, dialyzed and used as source of MTg or RTg. HTg 
purified similarly from frozen human thyroid gland was kindly provided by Dr. 
G. Carayanniotis. 
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3. 2 CULTURE MEDIA, CELL LINES AND MONOCLONAL ANTIBODIES 
All assays were performed in DMEM medium (GffiCO) supplemented with 
10-20% fetal bovine serum (FBS) (Bioproducts for Science, Indianapolis, IN, 
USA), 20 mM HEPES buffer, 2 mM L-glutamine, 100 U/ml penicillin, 100 J,Lg/ml 
streptomycin (all from GIBCO,) and 5 x 1o-5 M 2-mercaptoethanol (2-ME) 
(Sigma, St. Louis, MO, USA). For cell washings HBSS (GffiCO) or PBS (pH 7.4) 
was used. 
The BW5147a-~- variant (White et al., 1989) was a kind gift of Dr P. 
Marrack (National Jewish Centre for Immunology and Respiratory Medicine, 
Denver, CO, USA). The antigen presenting hybridoma cell line TA3 (H-2Ad/k, 
H-2Ed/k) (Allen et al., 1985) was a kind gift of Dr. L.H. Glirncher at Harvard 
Medical School, and was courteously provided by Dr. T. Watts at the University 
of Toronto. The IL-2-dependent CTLL-2 line (Gillis and Smith, 1977) was 
purchased from ATCC. 
Anti-a~+ -fluorescein isothiocyanate (FITC), anti-CD4+ -FITC and anti-
CD8+-phycoerythrin (PE) conjugates were purchased from GffiCO. Hybridomas 
specific for Kk (16-3-225 , Ig2a) (Ozato et al., 1980), I-Ak [k,r,f, or s] (10-3.6.2, 
Ig2a) (Oi et al., 1978), I-Ek (14-4-4S, Ig2a) (Ozato et al., 1980), ok (15-5-SS, Ig2a, 
cross reacts with Kd,f) (Ozato et al., 1980), and influenza A nucleoprotein(H16-
L10-4RS, IgG2a) (Yewdell et al., 1981) were obtained from the American Type 
Culture Collection, (Rockville, MD, USA) and the respective mAbs were purified 
from culture supernatants on protein G-Sepharose 4 Fast Flow affinity 
chromatography columns (Pharmacia, Baie d'Urfe, Quebec, Canada). Briefly, the 
harvested supernatant was centrifuged at 12,000 g for 20 min. and loaded on to 
the Protein G-sepharose column which had been equilibrated with phosphate 
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buffer (pH 7.0). After the supernatant had passed through, 100 ml each of acetate 
buffer pH 4.0 (elution buffer I) and glycine-HCl buffer pH 2.4 (elution buffer II) 
were passed. The antibody containing fractions were quickly pooled, dialyzed 
against distilled H20 and concentrated on Diaflow membranes using Amicon 
ultrafiltration cell, model 8050 (Amicon, Danvers, MA, USA). The mAb 
preparation was filter-sterilized, and prior to storage its protein content was 
estimated by measuring the absorbance at 280 nm on a Beckman DU-64 
spectrophotometer (Beckman, Fullerton, CA, USA). Antibody concentration 
(mg/ ml) = absorbance @ 280 x dilution of the sample I 1. 45. 
3. 3 THYROGLOBULIN PEPTIDE-SPECIFIC T -CELL HYBRIDOMAS 
3 .3 .1 Generation of hybridomas 
T -cell hybridomas were generated following a slightly modified method of 
Perkins et al., (1991). Mice were immunized s. c. at the base of the tail with 100 
nmol peptide in 100 J..Ll of CFA emulsion (with Mycobacterium butyricum, Difco 
Laboratories Inc., Detroit, MI, USA). Ten days later, the inguinal lymph nodes 
were collected aseptically and single cell suspensions (LNC) were prepared in 
DMEM 10% FBS culture medium. After centrifugation and washing, 4 x 106 
cells/ml were cultured in the presence of 10 J..Lg/ml peptide used for 
immunization, at 370 C in a 5% C02, 95% air, humidified incubator. After 4 
days, viable lymphocytes were isolated on Ficoll Paque (Pharmacia, Canada) 
and fused with BW5147 a-~- cells using polyethylene glycol 1500 (Boehringer 
Mannheim Biochemicals, Indianapolis, IN, USA) at a 1:3 ratio of lymphocytes to 
tumour cells. After the fusion step, gradual addition of DMEM without FBS and 
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suspension of the cells in 40 ml of DMEM with 20% FBS were performed as 
described (Perkins et al., 1991). Hybridomas usually appeared in microwells after 
7-10 days of culture and were gradually transferred from 
hypoxanthine/ aminopterin/ thymidine (Sigma)- to hypoxanthine/ aminopterin 
(Sigma)- containing medium and finally to complete medium. Peptide-specific 
hybridomas were cloned by limiting dilution at 0.3 cell/well using 1% 
syngeneic RBC as filler cells. 
3. 3. 2 Activation of hybridomas 
3. 3. 2. 1 Mitomycin-C treatment of splenocytes 
Spleens were collected aseptically from naive healthy mice and single cell 
suspensions were prepared by passing the spleen tissue through sterile stainless 
steel mesh (Sigma, St. Louis, MO, USA) and the resulting cell suspension was 
vigorously pipetted several times to obtain a uniform suspension of cells. The 
cells were washed three times with DMEM, adjusted to 5 x 107 /ml and 
incubated with 100 J.Lg of mitomycin-C (Sigma, St. Louis, MO, USA) for 20 min. 
at 370C avoiding exposure to light. The cells were washed thrice with DMEM 
and finally resuspended in DMEM with 10% FBS to be used as APC. 
3. 3. 2. 2 Glutaraldehyde treatment of APC 
T A3 cells were washed thrice in serum free DMEM and once in PBS and cell 
concentration was adjusted to 5 x 106 cells/mi. The cells were treated with 
glutaraldehyde (0.1% final concentration) for 30 seconds and an equal volume of 
freshly prepared 0.2M glycine in PBS was immediately added to the cells. The 
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cells were washed twice with serum free DMEM and once with DMEM with 10% 
FBS. The cell concentration was adjusted to 105 I ml and used in T -cell 
hybridoma activation assays. 
3. 3. 2. 3 CTLL-2 proliferation assay 
CTLL-2 were maintained in continuous culture by growing in DMEM -10% 
FBS supplemented with 10% culture supernatant from rat spleen cells stimulated 
with con A (2 ~g/ml) for 72 hours. Residual con A in the supernatant was 
inactivated by a-methylmannoside (50 mM). In flat-bottomed wells of microtiter 
plates, 10S hybridoma T cells and an equal number of TA3 I LS 102.1 or 106 
mitomycin-C treated spleen cells were cultured for 24 hours with or without 
MTg(2495-11) 10 ~g/ml in a total volume of 200 J,Ll culture medium per well. 
Then, 50 Jll of supernatant was harvested from each well, transferred into new 
plates, and kept frozen for more than 2 hat -70 °C. Upon subsequent thawing, 
104 CTLL-2 cells were added per well and 18 h later, 3[H]-thymidine {lJ.LCi/well) 
(Amersham, Canada) was added. The cells were harvested 6 hours later using a 
semi-automated cell harvester (Skatron Inc. Sterling, VA, USA) and incorporated 
thymidine was counted in a liquid scintillation counter (LS3801, Beckman 
Instruments, Palo Alto, CA, USA). Peptide-specific hybridomas were cloned by 
limiting dilution at 0.3 cell/well using 1% syngeneic RBC as filler cells. 
3. 3. 3 FACS analysis 
Expression of TCR ap, CD4 and CDS was assessed by direct labeling of T-
cell hybridomas as described by Stewart (1990). Briefly, 1 x 106 cells were 
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washed twice in P AB (PBS containing 0.1% sodium azide (Sigma, St. Louis, MO, 
USA) and 0.5% BSA (Pharmacia, Canada), and were incubated with a control IgG 
(specific for influenza A nucleoprotein) (30 J.Lg in 10-20 J.Ll for 20 min.) to block 
potential Fe receptors. The cells were washed once in PAB, stained with 11lg 
(4Jll} of labeled conjugates for 30 min., washed twice with P AB and finally 
suspended in 1 ml cacodylate buffer (pH 7.2) containing 1% paraformaldehyde 
(Sigma, St. Louis, MO, USA}. FACS analysis was performed using a FACStar 
Plus analyzer (Becton-Dickinson Inc.,}. Labeling procedures were carried out at 
4°C. 
Phenotypic characterization of TCR-V~ family gene expression by T-cell 
hybrids was carried out in a two-step method. 10S hybrid T cells were first 
incubated on ice for 30 min. in separate Eppendorf tubes with culture 
supernatant (in appropriate dilution) containing mAb-specific for TCR-V~ 2 
(B20, 3, 4, 5, 6, 7, 8.1/.2/ .3, 9, 11, 13, 14 or 17 (kindly provided by Dr. C. Guides, 
University of Toronto}. Following 2-3 washes with PAB, the cells were incubated 
again for 30 min. with anti-hamster IgG (in case of V~ 3), anti-rat IgM (in case of 
V~14) or anti-mouse or rat IgG (in case of all other V~s) as a second Ab-FITC 
conjugate. Following two washes in PAB, the cells were fixed by suspending in 
1.0 ml cacodylate buffer (pH 7.2) containing 1% paraformaldehyde and analyzed 
as mentioned earlier. 
3. 4. ASSESSMENT OF PEPTIDE IMMUNOGENICITY 
3. 4. 1 LNC proliferation assays. 
Mice were injected s. c. with peptides (50 nmol) in 100 J.Ll of CFA (with 
Mycobacterium buhpicum, Difco Laboratories Inc., Detroit, :MI, USA) emulsion at 
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the base of the tail. After 10-11 days, draining inguinal LNC were collected 
aseptically, washed with culture medium, and cultured (4 x 105 cells I well) for 
4 days in the presence of appropriate antigen in 200 Jll microcultures. Eighteen 
hours prior to harvesting, 1J.1Ci of 3[H]-thymidine was added to each culture 
well in 25 Jll of medium. Harvesting and counting of the incorporated 
radioactivity was done as described earlier (section 3. 3. 2. 3). Stimulation index 
is defined as (cpm in the presence of Ag/ cpm in the absence of Ag). 
3. 4. 2 Cytokine assays 
The IFN-y and IL-4 levels in culture supernatants were determined using 
Biotrak kits (Amersham International, Buckinghamshire, UK). Briefly, 50 Jll of 
the culture supernatant was added to microwells for 2 h. After the prescribed 
number of washings, the wells received 100 Jll of the appropriate IFN-y- or IL-4-
specific Ab-horseradish peroxidase conjugate and were incubated further for one 
hour. Following a wash, 100 Jll of tetra-methyl- benzidine substrate was added to 
the wells and, 30 min. later, the optical density (OD) was measured at 450 nm 
using an automated microplate reader (Molecular Devices, Sunnyvale, CA, 
USA). 
3. 4. 3 Assessment of antibody 
The presence of specific serum IgG was determined by enzyme linked 
immunosorbent assay (ELISA). Microwells of polyvinyl chloride plate 
(Dynatech Laboratories, Chantilly, VA, USA) were coated overnight with 1 Jlg of 
MTg, 4 Jlg of MTg(2495-2513), or 8 Jlg of human or rat Tg(2695-2706) dissolved in 
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carbonate buffer pH 9.6. After emptying, the wells, they were blocked for one 
hour with 0.1% BSA in PBS. Sera samples were incubated for 1 hour with Ag 
and following three washings with PBS containing Tween-20, 100 J.Ll of alkaline 
phosphatase-conjugated goat anti-mouse IgG (Sigma, St. Louis, MO, USA) as the 
second antibody was added to each well. One hour later, plates were washed 
thrice with PBS containing Tween-20, and p-nitrophenyl phosphate substrate 
(Sigma, St. Louis, MO, USA) was added (1 mg/ml in 10% diethanolamine, 100 
J.Ll/well) and incubated for one hour. Absorbance of the p-nitrophenolate 
product was measured at 405 nm as described above. 
3. 5 THYROIDITIS INDUCI10N 
3. 5. 1 Direct challenge with peptides 
To induce EAT directly, mice were primed with 100 nmol of peptide in CFA 
(with Mycobacterium butyricum, Difco Laboratories Inc., Detroit, MI, USA) 
emulsion and boosted 21 days later with 50 nmol of peptide in IF A. Thirty five 
days after priming, thyroids and sera were collected from the mice. 
3. 5. 1 Adoptive transfer 
To induce EAT by adoptive transfer, donor mice were primed with 50 nmol 
of rat or human Tg-peptides or 50 J.Lg of OVA in CFA. Ten days after priming, 
inguinal LNC were harvested and cultured for 72h in the presence of 
immunizing peptide (10 !lg/ml). After washing twice with serum free DMEM 
and once with HBSS, 2 x 107 cells suspended in HBSS were injected i. p. into each 
of the recipients. In some experiments, control mice received the same number of 
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con A-activated syngeneic splenocytes. Fourteen days later, thyroid glands and 
sera were collected. 
3. 5. 3 Assessment of thyroiditis 
Formalin-fixed thyroids were embedded in methacrylate and 
approximately 40 sections, 3.0 Jlm thick, were obtained at 36 Jlm intervals from 
each gland. The sections were stained with haematoxylin and eosin, and scored 
for the presence of mononuclear cell infiltration as follows: 1= interstitial 
accumulation of cells between 2 to 3 follicles; 2= one or two foci of cells at least 
the size of one follicle; 3= extensive infiltration, 10-40% of total area; 4= extensive 
infiltration, 40-80% of total area and 5= extensive infiltration, > 80% of total area. 
3. 6 CHARACTERIZATION OF TCR-V~ GENE USAGE BY RT-PCR 
3. 6. 1 RNA extraction 
Total RNA was extracted from 5 x 106 hybrid T cells or spleen cells using 
RNAzol (Biotecx Laboratories, Inc. Houston, TX, USA)) according to the 
manufacturer's instructions. Briefly, 5 x 106 hybrid T cells, were washed twice 
with serum-free DMEM and at least once with PBS, and were then completely 
solubilized in 1 ml of RNAzol. After adding 200 Jll of chloroform, the tubes were 
vortexed and centrifuged at 12,000 g for 15 min. The upper aqueous phase 
containing RNA was transferred into a fresh Eppendorf tube and, after adding 
isopropanol (in 1:1 ratio) the tube was left overnight at 4°C. The RNA was 
precipitated by centrifuging at 12,000 g for 15 min., washed once with 75% 
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ethanol, and after air drying for 10 min., it was finally dissolved in diethyl-
pyrocarbonate (DEPC)-treated water and stored at -70°C. 
3. 6. 2 eDNA preparation 
First strand eDNA synthesis was performed using a kit from Pharmacia 
(Uppsala, Sweden). Briefly, five micrograms of RNA (in 20 fJ.l volume made up 
with DEPC-treated water) was placed in a Eppendorf tube and was denatured 
by heating at 65°C for 10 min. and then chilled on ice. In a separate tube, 11 f.l.l 
of the reaction mix, 1f.l.l of oligo [dT] n- primer, 1 J.l} of dithiothreitolsolution and 
were completely mixed together and finally, the RNA was added. The eDNA 
synthesis reaction was allowed to proceed at 37°C for 1 hand at the end, it was 
terminated by heating the tube at 65°C for 10 min. The eDNA was stored at -
70°C. 
3. 6. 3 Amplification by RT-PCR 
For PCR amplification, 2 fJ.l of eDNA was incubated with 0.4 mM dNTP 
mix, 4 mM MgCl2, 2.5 units of Taq DNA polymerase (Thennus aquaticus strain 
YTl) (GIBCO, BRL), 20 pmol of each primer, and PCR buffer in a total reaction 
volume of 50 fJ.l. Forward primers specific for V~ 17 (Waters et al., 1992), other 
V~ families and a reverse C~ primer (Casanova et al., 1991) were synthesized by 
the GSD Center for Biomaterials (Toronto, ON, Canada). Forward and reverse 
primers for glyceraldehyde-3-phosphate dehydrogenase (GADPH) were selected 
from Gu et al., 1995). A 30-cycle step program (95°C for 1 min., 56°C for 1 min., 
and 72°C for 1 min.) was preceded by a 5-min. denaturation step at 94°C and 
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was followed by a 7-min extension step at 72°C (Perkin-Elmer DNA Thermal 
Cycler, Cetus, Norwalk, CT, USA). 
3. 6. 4 Analysis of PCR products 
The amplified PCR products were subjected to electrophoresis on 1.5% 
agarose gels containing ethidiurn bromide (0.5 Jlg/ml). Gel images were 
photographed (film # 667, ISO 3000/36 from Polaroid Corp. Cambridge, MA, 
USA) using Photo-Documentation Hood (FisherBiotech Electrophoresis Systems 
FB-PDH-1314, Fisher Scientific, Pittsburg, PA, USA) or recorded using a 15-500 
Digital Imaging system (Alpha Innotech Corp., San Leandro, CA, USA). 
CHAPTER 4 
MAPPING OF THYROGLOBULIN EPITOPES: PRESENTATION OF A 
PATHOGENIC 9mer PEPTIDE BY DIFFERENT MOUSE MHC CLASS II 
ISO TYPES 
4.1 SUMMARY 
The 17mer MTg(2495-ll} peptide has been reported to induce EAT in H-2k 
mice, a process requiring expression of Ek genes, and in H-25 mice that lack 
functional H-2E molecules. To test whether this apparent discrepancy was due to 
recognition of distinct MTg(2495-11) determinants in each strain, we mapped 
minimal T-cell epitopes within MTg(2495-11) and examined their pathogenicity 
in C3H (H-2k) or SJL (H-2S) mice. Truncation analysis using MTg(2495-ll)-
specific, CD4 + hybridomas from C3H mice identified two overlapping 
determinants, (2496-2504) and (2499-2507), that were restricted by the Ek and Ak 
molecules, respectively. Subsequent challenge of C3H and SJL mice with these 
9mer peptides revealed that the Ek_restricted (2496-2504) determinant elicited 
EAT and specific proliferative LNC responses in both strains suggesting 
recognition in the context of AS, since this is the only class II molecule expressed 
in SJL mice. This was further confirmed by blocking of the proliferative LNC 
response by an AS-specific mAb. In contrast, the Ak-restricted (2499-2507) 
determinant induced weak EAT and no proliferative LNC reponses in either 
strain. These data: (1) delineate the 9mer (2496-2504) peptide as a minimal 
Some of the results presented in this chapter have been published as: 
Rao V.P., BaJasa B., and Carayanniotis G. (1994). Mapping of thyroglobulin epitopes: presentation 
of a 9mer pathogenic peptide by different mouse MHC class II isotypes. Immunogenetics 40, 352-
359. 
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Tg T-cell epitope with direct pathogenic potential in mice and (2) highlight the 
use of non allelic MHC class II molecules for the presentation of this peptide in 
mice of different H-2 haplotypes. 
4. 2 INTRODUCfiON 
The MTg(2495-11) has been previously identified as a thyroiditogenic 
sequence in mice (Chronopoulou and Carayanniotis, 1992) and rats (Balasa and 
Carayanniotis 1993) and consists of nondominant determinants at the B or T -cell 
level. Despite its nondominant nature, MTg(2495-11) induces EAT with a genetic 
pattern similar to that obtained with intact Tg, and elicits strong specific T-cell 
responses as well as IgG responses that cross react with Tgs from different 
species (Chronopoulou and Carayanniotis, 1992). For these reasons, MTg(2495-
11)-mediated EAT provides an excellent model for studying the 
immunoregulatory mechanisms leading to mononuclear infiltration of the 
thyroid and hypothyroidism- the main symptoms of HT (Weetman, 1992). 
Earlier work (Chronopoulou and Carayanniotis, 1993) demonstrated that Ek 
expression is a necessary but not sufficient requirement for EAT induction with 
MTg(2495-11) and suggested involvement of the Kk and/ or Ak loci in the disease 
process. In apparent contrast to these findings, however, SJL mice that lack H-2E 
molecules, were found to be EAT-susceptible after MTg(2495-11) challenge 
(Chronopoulou and Carayanniotis, 1992). Since fine epitope mapping in the 
MTg(2495-11) sequence had not been attempted, this discrepancy between k and 
s mice could be accounted for by recognition of either a) distinct pathogenic 
epitopes within MTg(2495-11) or b) identical pathogenic epitope(s) that could be 
presented in the context of both Ek and AS molecules. In the present study we 
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have addressed this issue by mapping the minimal T-cell epitopes within 
MTg(2495-11) using cloned T-cell hybridomas and by examining the 
immunopathogenicity of these epitopes in C3H (H-2k) and SJL (H-25) mice. 
4. 3 RESULTS 
4. 3.1 Generation and phenotypic analysis of MTg(2495-11)-specific, cloned 
T·cell hybridomas 
Following the fusion of MTg(2495-11)-primed C3H-derived LNC with 
BW5147 a-~- thymoma cells, 11 out of 788 seeded wells showed hybridoma 
growth and of those, cells from 8 wells were finally tested for peptide specificity 
using TA3 cells as APC. The results were shown in Figure 4. 1. Hybrids 4A2, 
4A12 and 4B7 isolated from three different wells responded specifically to 
MTg(2495-11) and were cloned by limiting dilution (0.3 cells I well). The 
MTg(2495-11)-specific reactivity of two representative clones, one from each of 
the hybrids 4A2 and 4A12, is shown in Figure 4. 2. Both hybrid clones 
responded by secreting IL-2 upon incubation with MTg(2495-11) (1-20 J.Lg/ml 
final concentration range) and mitomycin-C-treated syngeneic spleen cells 
(APC). No response was observed against ovalbumin (OVA) (control antigen). 
FACS analysis after direct labeling of the hybridomas with FITC- or PE-
conjugated mAb, indicated that both the clones were derived from a TCR af3+, 
CD4+ CDS- T-cell subset (Figure 4. 3). 
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Figure 4. 1 Screening of C3H mice-derived T cell hybridornas for specificity to 
MTg(2495-11). Using T A3 celJs as APC, peptide specific activation ofT-cell hybrids 
was assayed by their IL-2 release which in turn was assessed by proliferation of 
CTLL-2. Data represent mean cpm values of triplicate wells. SO values were< 10% 
of the means. 
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Figure 4. 2 IL-2 release by T-cell hybridoma clones 4A2 and 4A12 upon 
incubation with MTg(2495-11) or OVA (control). The hybridomas were 
cultured with mitomycin-C- treated syngeneic splenic APC and peptide at 
the concentrations shown. After 24 h of incubation, the IL-2 content in culture 
supernatants was assessed by the proliferation of the IL-2 dependent CTLL-2 
line as described in Materinls and methods. Data represent mean cpm values of 
triplicate wells. S.D values were <10% of the means. Background means of 
cpm in the absence ofTgPl were 4A2 = 4,205 and4A12 = 3,519. 
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FLUORESCENCE INTENSITY 
Figure 4. 3 Fluorocytometric profile of the 4A2 and 4A12 T -cell hybridoma 
clones after direct labeling with the indicated mAb. The phenotypic profile of the 
BW5147 a.-13- fusion parent (control) is shown in the background. 
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4. 3. 2 MHC-restriction profile of MTg(2495-11)-reactive hybrids 
The MHC-restriction profiles of the 4A2 and 4A12 clones were determined 
using a panel of blocking mAbs specific for different MHC products and the TA3 
cell line as a source of APC. As shown in Figure 4. 4, the MTg(2495-11)-mediated 
activation of the 4A2 clone was blocked by an Ek..specific mAb but not by mAb 
directed against Kk, Ak, and nk products. In contrast, the MTg(2495-11)-specific 
activation of the 4A12 clone was blocked only by the mAb directed against the 
Ak molecule. The observed MHC-restriction pattern of the C3H-derived hybrids 
was further confirmed by using splenic cells from intra-H-2 recombinant mice as 
APC (Table 4. 1). The Ek..restricted 4A2 clone recognized MTg(2495-11) on 
BlO.BR and B10.A(2R) cells that express H-2E products but was unreactive with 
B10.A(4R) APC which do not express functional E molecules. In addition, the 
4A2 hybrid was unresponsive with BlO.A(SR) APC that express a hybrid H-2E 
heterodimer suggesting a critical role for the Epk chain in the recognition 
process. On the other hand, the Ak..restricted 4A12 clone responded to 
MTg(2495-11) only in the presence of APC expressing Ak products confirming 
the inhibition assay results (Figure 4. 4). These data raised the possibility that 
distinct MTg(2495-11) epitopes are recognized by T cells in C3H mice. We 
proceeded to test this by peptide truncation analysis. 
4. 3. 3 Two overlapping 9mer T -cell epitopes are present within the 
17mer MTg(2495-11) sequence 
The clones 4A2 and 4A12 were initially tested against a peptide panel 
(Figure 4. 5) consisting of the MTg(2495-11) sequence (pep. 1) and 13 shorter 
peptides truncated by one a. a. at the N-terminal (peptide no. 2-6) or the C-
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Figure 4. 4 mAb-mediated blocking of MTg(2495-11)-specific recognition by the 
cloned T-cell hybrids 4A2 and 4A12. In triplicate wells, 10S T cells and 10S TA3 
cells, used as APC, were cultured with MTg(2495-11) (10 JJg/ml) and the 
indicated mAb specific for class I or class II MHC. The concentration of IL-2 in 
the supernatant was assessed by the proliferation of the IL-2-dependent CTLL 
line. Background cpm means in the absence of antigen were 4A2 = 1,094 and 4A 12 
=528. 
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Table 4. 1 Activation of T-cell hybrids 4A2 and 4A12 using splenic APC from intra- H-2 recombinant mice 
APC 
source 
810. 8R 
BlO. A(2R) 
810. A(4R} 
810. A(SR) 
H-21oci 
K APAa E~ Ea. D 
k 
k 
k 
b 
k 
k 
k 
b 
k k 
k k 
(k)¥ - t 
b k 
k 
b 
b 
d 
4A2 
MTg(2495-11) 
28,9851 
36,289 
2, 750 
3,329 
medium 
3,603 
3,382 
4,365 
2,943 
4A12 
MTg(2495-11) 
19,774 
22,509 
21,336 
2,723 
.. 
medium 
3, 639 
3, 913 
3,393 
2, 139 
,. 106 mitomycin-C-treated splenocytes, used as APC, and 105 hybrids were cultured with or without peptide in 
triplicate microwells. After 24h, well supernatants (50 1.tl) were collected and frozen for at least 2h at -700 C before 
they were assayed for IL-2 activity. 
'll Mean cpm values of triplicate wells obtained from peptide titration curves represent the response to Tg-peptide at 
a final concentration 20 Jlg per ml of culture as measured through the 3[H]-thymidine uptake of the IL-2-dependent 
CTLL line. Standard deviations did not exceed 10% of the mean values. 
t No gene product; ¥ Not expressed at the cell surface. 
Peptide 
No. 2495 2503 2511 
I I I 
4A2 4A12 
1. GLINRAKAVKQFEESQG 
2. L I N R A K A V K Q F E E S Q G 
a INRAKAVKQFEESQG 
~ NRAKAVKQFEESQG 
L RAKAVKQFEESQG 
~ AKAVKQFEESQG 
7. G L I N R A K A V K Q F E E S Q 
8. G L I N R A K A V K Q F E E S 
9. G L I N R A K A V K Q F E E 
10. G L I N R A K A V K Q F E 
11. G LIN R AKA V K Q F 
12. G L I N R A K A V K Q 
13. G L I N R A K A V K 
14. G L I N R A K A V 
15. L I N R A K A V K Q F E 
16. R A K A V K Q F E 
17. L I N R AKA V K 
0 100 200 0 100 200 
3 [H]-thymldlne uptake (cpm x 10-3) 
Figure 4. 5 Truncation analysis forT-cell epitope mapping within MTg(2495-11) using T cell hybrid 
clones 4A2 and 4A12 and TA3 cells as APC. Peptides were used at a final concentration;Of 10 !lg/ml. 
Data represent means of triplicate cpm values of proliferating CTLL and reflect the relative IL-2 
content of supernatants during T-cell activation. S.D. values were <10% of the means. The standard 
single letter code is used to designate amino acid residues. In the presence of medium alone 
background cpm were 4A2 = 426, 4A 12 = 633. 
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terminal (peptide no. 7-14) of MTg{2495-11). TA3 cells were used as APC and 
final peptide concentration was kept constant at 10 Jlg/ mi. It was found that 
reactivity of the Ek- restricted 4A2 clone was lost upon the removal of the 
Leu2496 at the N-terminal (pep. 3) or the removal of the Lys2504 at the C-
terminal (pep. 14), thus delineating the H-2E-binding epitope as a 9mer sequence 
with a. a. coordinates (2496-2504). On the other hand, removal of the Arg2499 
(pep. 6) or the Glu2507 (pep. 11) abrogated the activation of the Ak-restricted 
4A12 clone, revealing the presence of a second 9mer T-cell epitope (2499-2507) 
within MTg(2495-11). The reason for the lack of response of 4A12 to pep. 9 is not 
clear but may reflect lack of Ak-binding due to the presence of two negatively 
charged Glu residues at the carboxyl end. Subsequent testing of the above clones 
against the 12mer peptide 2496-2507 containing the overlapping epitopes (pep. 
15) or the 9mer peptide epitopes themselves (pep. 16 and 17) confirmed the 
distinct specificities of these clones. In dose-response experiments, subsequent 
comparison of MTg(2495-11) with the minimal epitopes showed that the peptides 
LINRAKA VK and RAKA VKQFE were not significantly different, on a molar 
basis, from the 17mer MTg(2495-ll), in their capacity to activate the appropriate 
hybridomas (Figure 4. 6). 
4. 3. 4 Presentation of Ek_ but not Ak_restricted MTg(2495-11) epitope 
requires live APC 
Since peptide antigens may also undergo processing prior to their 
presentation by APC to T cells (Fox et al., 1988), we ascertained whether 
presentation toT cells of the pathogenic epitopes within the 17mer MTg(2495-11) 
requires peptide internalization and processing by APC. To address this, 
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Figure 4. 6 Comparison between MTg(2495-11) and its 9mer T-cell epitopes for 
their capacity to activate the T-cell hybrids 4A2 and 4A 12. TA3 were used as 
APC. Data represent mean cpm of triplicate wells in the CTLL assay. S.D. 
values were <5% of the means. Background means of cpm in the absence of 
antigen were: 4A2 = 5,155 and 4A12 = 5,143. 
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glutaraldehyde-treated TA3 cells (fixed APC) were used to activate the T-cell 
hybridomas 4A2 and 4A12 as described in Materials and Methods. The Ek-
restricted clone 4A2 responds to the minimal peptide (2496-04) on fixed T A3 
(Figure 4. 7) as well as on live TA3 (Figure 4. 6). On the other hand, the clone 
responded to the 17mer (2495-11) on live APC but did not respond to the 17mer 
or a 12mer peptide (:).,4Q6.-07) on fixed APC (Figure 4. 7), suggesting that 
presentation of the minimal peptide (2496-04) requires internalization and 
processing of (2495-11) or (2496-07) by APC. In contrast, the Ak-restricted hybrid 
clone 4A12 responded not only to the minimal peptide (2599-07) but also to the 
17mer and 12mer peptides on fixed APC (Figure 4. 7). These data confirm that 
some peptide Ag need further processing by APC and show that two 
overlapping T-cell determinants present within a 17mer peptide can exhibit 
differential processing requirements. 
4. 3. 5 Immunopathogenicity of MTg(2496-04) in H-2k and H-2s mice 
T -cell recognition of the LINRAKA VK epitope in the context of Ek or AS 
molecules could explain why MTg(2495-11) induced H-2Ek- controlled EAT ink 
mice but was equally pathogenic in SJL mice lacking H-2E expression 
(Chronopoulou et al., 1992). To confirm the immunogenic properties of this 9mer 
peptide, C3H or SJL mice were immunized with 50 nmol of MTg(2495-11) or the 
9iner peptides delineated above and 9-10 days later the proliferative responses of 
the inguinal LNC were examined. Results from two independent experiments 
(Table 4. 2) demonstrated that addition of the Ek-restricted LINRAKA VK (2496-
04) epitope in culture induced significant responses in C3H and SJL LNC 
following in vivo priming with MTg(2495-11) or the 9mer peptide itself. On the 
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Figure 4. 7 E~but not A~restricted epitope within the MTg(2495-11) needs processing by 
APC. 105 glutaraldehyde (0.05%)-treated T A3 cells and an equal number of 4A2 or 4A12 
hybrid cells were cultured in the presence of varying concentrations of above mentioned 
antigens. The IL-2 content of supernatants was measured by CTLL proliferation assay as 
described in Materials and methods. The data represent mean cpm values of triplicate 
wells. SD values were< 10% of the means. 
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Table 4. 2 Proliferative LNC responses (S. I.) to 9mer T cell epitopes within the MTg(2495-11) 
Antigen in vitro (20 J.lg mr1) 
Antigen 
• • It 
m VIVO MTg(2495-11) RAKAVI<QFE LINRAKAVK 
Exp. Strain: C3H SJL C3H SJL C3H SJL 
MTg(2495-11) 1 5.4 t 24.5 1.2 1.9 2.0 6.6 
2 8.1 19.9 1.2 1.1 3.2 ~ 
RAKAVKQFE 1 1.8 1.6 1.4 1.8 1.1 1.5 
2 1.5 1.1 1.4 1.9 1.6 1.9 
LINRAKAVK 1 1.6 10.5 1.0 1.9 2.1 18.8 
2 M 2.1 1.4 1.1 5.3 9.6 
• Mice were s.c. primed with 50 nmol of peptide in CFA, 10 days before collecting the 
inguinal LNC. 
t Stimulation index values >2 are considered significant and are underlined. Background 
cpm (no added antigen in culture) were: For C3H: MTg(2495-11), exp.l = 11,721, exp.2 =524; 
RAKA VKQFE, exp.1 = 3,268, exp.2 = 7,808; LINRAKA VK, exp.1 = 5,188, exp.2 = 8,584. For 
SJL: MTg(2495-11), exp.l = 2,870, exp.2 =2,396; RAKAVKQFE, exp.l = 3,462 exp.2 =3,485; 
LINRAKAVK, exp.1 = 5,030, exp.2 = 9,736 
~ 
\0 
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other hand, the Ak-restricted RAKA VKQFE (2499-07) epitope did not induce 
significant LNC responses in either strain regardless of the priming antigen used. 
Also cross-reactivity, at the level of LNC proliferation, was not observed between 
the two minimal epitopes. These data provided strong evidence that the (2496-
04) peptide is recognized in association with H-2AS, since this is the only MHC 
class II molecule expressed by SJL mice. This was further confirmed by a 
blocking experiment in which the proliferative response of SJL LNC to the (2496-
04) epitope was inhibited in the presence of a m.Ab specific for AS determinants 
but not by an isotype-matched control m.Ab specific for influenza A 
nucleoprotein (Figure 4. 8) 
Direct challenge of C3H or SJL (5 mice per strain) with the immunogenic 
epitope LINRAKA VK (2496-04) led to significant EAT induction in both strains 
to a degree equal to that induced by MTg(2495-11) (Table 4. 3). All C3H mice 
and 4 out 5 SJL mice developed EAT following challenge with the (2496-04) 
epitope; similarly, all C3H and 3 out of 5 SJL developed EAT with MTg(2495-11). 
On the other hand, the epitope RAKA VKQFE (2499-07) that failed to induce 
proliferative responses, caused only focal infiltration in 1 out of 5 C3H and 2 out 
of 4 SJL mice. This immunization regime also induced significant IgG responses 
to MTg(2495-11) in SJL but not C3H animals (Table 4. 3) primed with the (2496-
2504) peptide. In contrast, MTg(2495-11)-specific antibodies were not induced to 
a significant extent by the (2499-07) peptide. Unlike MTg(2495-11), however, 
which elicits MTg-reactive IgG (Table 4. 3), reactivity to MTg was not observed 
by IgG induced by either minimal epitope. Thus, it is unlikely that such 
antibodies are involved in the disease process. 
anti-9 10 H-2A 
40 
control 
mAb 10 
40 
nomAb 
0 
71 
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Stimulation Index 
Figure 4. 8 Inhibition of the MTg(2496-04)-specific proliferative response of 
LNC from SJL mice, in the presence of anti-A5 or anti-influenza-NP m.Ab. 
Blocking mAb were used at the indicated concentrations. The final peptide 
concentration was 10 ~g/ ml. A control mAb specific for influenza A 
nucleoprotein was used, of the same subclass UgG2a) as the anti-A mAb. 
In the absence of antigen, background cpm were = 18, 469. Results 
represent cpm + SD of triplicate values. Background stimulation (not 
shown) was obtained in the presence of another Tg peptide, MTg(2695-13). 
Table 4. 3 EAT induction with the 9mer Tg T-cell epitopes in C3H and SJL mice 
Peptide 
challenge 
in vivo* 
C3H mice 
MTg(2495-11) 
RAKAVKQFE 
LINRAKAVK 
SJL mice 
MTg(2495-11) 
RAKAVKQFE 
LINRAKAVK 
Infiltration Index t 
0 0.5 1 
3 1 
4 1 
3 1 
2 1 1 
2 2 
1 1 2 
2 
1 
1 
1 
1 
Mice with 
thyroiditis 
5/5 
1/5 
5/5 
3/5 
2/4 
4/5 
Serum lgG response < O.D ® 405 nm )Y to 
MTg(2495-11) MTg 
1:20 1:80 1:20 1:80 
0.65 0.37 0.20 0.04 
<0.05 <0.05 <0.05 <0.05 
0.04 <0.05 0.02 <0.05 
1.35 1.42 0.86 0.71 
0.21 <0.05 0.06 <0.05 
0.71 0.20 0.06 0.02 
.. Mice were primed and boosted with appropriate peptide as described in Materials and Methods. EAT 
was assessed 5 weeks after the first challenge. 
t Severity of thyroiditis: 0.5 =interstitial accumulation of inflammatory cells distributed between two or 
more follicles; 1= one to two foci of inflammatory cells at least the size of one follicle; 2= extensive 
infiltration, 10-40% of total area. 
¥ Specific IgG assessed by an alkaline-phosphatase based ELISA in pooled sera from each group, tested 
at the dilutions shown. Microtiter wells were coated with 1 ~g mTg or 4 ~g MTg(2495-11) as described in 
Materials and methods. 
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4. 4 DISCUSSION 
The present data delineate the 9mer (2496-04) determinant as the shortest 
Tg peptide known to directly elicit EAT in mice. This peptide is equal in length 
to the only other known minimal T-cell epitope of Tg (a. a. 2551-58) containing 
thyroxine (T4) at position 2553 (Champion et al., 1991). However, the 
thyroiditogenic potential of the T 4-containing peptide has been shown only by 
adoptive transfers with peptide-specific LNC (Hutchings et al., 1992) and this 
peptide was described by Raitt and his colleagues, as being not directly 
pathogenic in mice (Hutchings et al., 1992). The (2496-04) epitope is recognized 
by the Ek-restricted 4A2 hybrid and this restriction pattern has been consistent 
within a large panel of peptide-specific T -cell hybridomas generated from 
various H-2k mice such as C3H, B10.BR, and CBA (see Chapter 5, section 5. 3. 2). 
The same 9mer peptide induces significant proliferative LNC responses in C3H 
(H-2k) as well as SJL (H-2S) mice. Blocking of the specific proliferation of SJL 
LNC in the presence of an anti-AS mAb confirmed recognition of this 9mer 
peptide in the context of AS, the only functional class II MHC molecule in SJL 
mice. 
Direct challenge of C3H and SJL by the (2496-04) peptide induces thyroid 
infiltration equivalent to that obtained after challenge with MTg(2495-11). 
Therefore, this determinant is likely to be the main pathogenic epitope within 
MTg{2495-11). This property of the (2496-04) determinant can explain why 
MTg(2495-11) was found earlier to be pathogenic in H-2S mice which lack 
functional E molecules but induced Ek-controlled EAT in H-2k mice 
(Chronopoulou and Carayanniotis, 1992; Chronopoulou and Carayanniotis, 
1993). It should be emphasized, however, that mapping of minimal MTg(2495-
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11) epitopes was not attempted with SJL T cells and at this stage it is unclear 
whether the LINRAKA VI< sequence represents a minimal thyroiditogenic 
peptide in SJL mice. It is possible that a nested epitope present within (2496-04) 
may mediate H-2s-restricted EAT. A rationale for such speculation can be 
derived from studies describing that T cells from different strains of mice 
recognize distinct determinant~ within the short myoglobin peptide [(110-121) 
Nanda et al., 1992)]. 
The lack of MTg(2495-ll) pathogenicity in BlO.A(SR) mice (Chronopoulou 
and Carayanniotis, 1993), which express hybrid <Ebb: Eak) molecules can also be 
explained if such class II molecules are unable to present the pathogenic peptide. 
The requirement for the Ebk chain for the presentation of the minimal (2496-04) 
epitope to the 4A2 T cells, selected in the context of <Ebk: Eak), tends to support 
this view. Thus, MTg(2495-11) pathogenicity may not be influenced by the 
simple presence (B10.A(SR)) or absence (SJL) of E molecules but it may pivot on 
the expression of class II heterodimers suitable in presenting the (2496-04) 
determinant. Under this hypothesis, MTg(2495-11) pathogenicity ink mice may 
not require concomitant expression of Ak or Kk molecules as previously 
suggested (Chronopoulou and Carayanniotis, 1993). 
The Ak-restricted (2499-07) epitope did not elicit LNC-proliferative 
responses in either strain but exhibited weak direct pathogenicity. This was a 
puzzling observation in view of the fact that both minimal peptides were 
mapped by IL-2-secreting T-cell hybrids isolated from the same fusion using 
MTg(2495-11)-reactive LNC. It is possible that T cells reactive with the (2499-07) 
determinant may proliferate in culture after they receive helper signals from Ek_ 
restricted T cells responding to the (2496-04) determinant. In that regard, 
75 
MTg(2495-11)-specific proliferation of rat LNC was found earlier to be blocked 
by both A- orE-specific m.Ab (Balasa and Carayanniotis, 1993). Also, the (2499-
2507) epitope may be recognized by Th cells that participate in the induction of 
humoral responses since strains such as B10.A(4R), do not mount proliferative 
LNC responses to MTg(2495-11) but do generate high titers of MTg(2495-11)-
specific IgG (Chronopoulou and Carayanniotis, 1993). On the other hand, it has 
been shown that non-proliferative T cells can adoptively transfer disease upon in 
vitro incubation with autoantigens (Hunter, 1986; Gregerson et al., 1989) and it is 
possible that a pathogenic role for (2499-2507)-specific T cells may emerge in 
adoptive transfer studies. Preliminary results have clearly shown that 
MTg{2495-11)-elicited T cells can transfer EAT in both C3H and SJL mice. 
The identified 9mer T -cell epitopes have identical a. a. sequences with their 
human homologues (Chronopoulou and Carayanniotis, 1992; Malthiery et al., 
1987) and they both carry the tetramer KAVK, one of the Rothbard and Taylor 
(1988) motifs that contributed to the identification of MTg(2495-11). The 
coordinates of the Ek-restricted epitope coincide with residues that delineate a 
common motif for Ek-binding peptides (Leighton et al., 1991) with the amino-
terminal Leu and lie residues being, respectively, eight and seven positions away 
from the C-terminaL In addition, the same epitope has a structural motif (Ile 
2497-Lys 2502) characteristic of peptides binding to HLA-DR molecules (Hill et 
aL, 1991) as well as motif (Ile 2497-Ala 2501) found in naturally processed 
peptides bound to HLA-DR8 (Chicz et al., 1993). On the other hand, the Ek-
restricted epitope does not obey a motif described for naturally processed AS-
binding peptides (Rudensky et al., 1992) even though it is recognized in the 
context of AS. This is not an uncommon finding, since natural ligand motifs by 
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incorporating constraints of both processing and binding may differ significantly 
from binding motifs (Falk et al., 1994; Englehard, 1994). The basis for the inability 
of MTg(2495-11) to bind directly to Ek but not Ak molecules on fixed APC as 
assessed by the activation ofT cell hybrids, is not clear, but might in part result 
from possible steric hindrance posed on the Ek..binding epitope (2496-D4) by the 
adjacent C-terminal residues. The observation that MTg(2495-11) or the minimal 
peptides activate T -cell hybrids equally well, suggests that there is no significant 
interference of flanking residues on peptide recognition, as has been described in 
other studies (Vacchio et al., 1989). The present findings do not exclude, 
however, the possible presence, within MTg(2495-ll), of other epitopes 
recognized by non IL-2-secreting T cells or epitopes restricted by class I MHC 
products. 
The variable selection of A or E molecules for the presentation of a 
pathogenic Tg peptide in mice of different MHC haplotypes has important 
implications in the quest for possible linkage of class II HLA molecules with 
susceptibility to thyroid disease. It is reasonable to expect that several peptides 
from each of the major thyroid autoantigens (Tg, TPO, and thyrotropin receptor) 
can be recognized by autoimmune T cells. If the binding of a pathogenic peptide 
to different rvrnc class n isotypes is a frequent event, and recognition of several 
such peptides initiates or potentiates the autoimmune process, a strong 
association of disease with the allelic class II products of any region (DP, DQ or 
DR) will be difficult or impossible to emerge at the population level or in family 
studies. Such complexity becomes apparent when defined thyroid antigen 
epitopes are used for the screening of autoreactive T cells. For example, Dayan 
and co-workers (1991) have described that ITL from a DR3-positive patient with 
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GO recognize the TPO peptides (535-551) and (632-645) in the context of DP2 and 
DQ2 respectively. Epidemiological studies have associated neither of these 
molecules with GD but instead have shown a weak association with DR3 (Farid 
et al., 1979; Allannic et al., 1980). That different loci on different haplotypes may 
account for susceptibility to the same disease has been dearly shown in 
pemphigus vulgaris, where the DR4 association is attributed to DRB1 ,.0402 allele 
whereas the DR6 association is attributed to the DQB1 ,.0503 allele (Scharf et al., 
1989; Nepom and Concannon, 1992). Our present data confirm this concept in 
the EAT model and further suggest that recognition of a single pathogenic T-cell 
peptide may account for such associations. 
CHAPTER 5 
RECRUITMENT OF MULTIPLE V~ GENES IN THE TCR REPERTOIRE 
AGAINST A PATHOGENIC THYROGLOBULIN PEPTIDE 
5.1 SUMMARY 
In autoimmune thyroid disease, although CD4 + T -cell subset(s) were clearly 
shown to be important, the question whether thyroid-infiltrating, autoreactive T 
cells are derived from a polyclonal or oligoclonal subset has been the subject of 
considerable debate. In the present study, we sought to address this issue while 
working with MTg(2495-ll). In mice of both k and s haplotypes, adoptive 
transfer of MTg(2495-13)-specific syngeneic LNC mediated severe thyroiditis. T-
cell hybrids generated from peptide-specific LNC from k mice (C3H, CBA, BlO. 
BR and BlO. A(4R) strains) showed expression of 4, 6, 8.2 and 14 plus some 
unknown V~ family TCR upon FACS analysis. In parallel, we determined 
whether the pathogenic (2496-04) sequence constituted a minimal T -cell epitope 
in SJL mice. In vitro recall assays based on LNC proliferation and cytokine 
release demonstrated that (2496-04) was a minimal T -cell epitope inducing a Thl 
type of response in SJL hosts. The TCR variability question was re-examined by 
testing the TCR V~ profile of IL-2-secreting hybridomas generated from this Thl 
subset. Ten clones derived from two independent fusions were found to utilize 
three V~ gene families (V~ 2, 4, and 17). To the extent that Tg or other 
Some of the results presented in this chapter have been published as: 
Rao V.P., Russell R.S., and Carayanniotis G. (1997) Recruitment of multiple V~ genes in the TCR 
repertoire against a single pathogenic thyroglobulin epitope. Immunology 91, 623--627 
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thyroid autoantigens encompass multiple pathogenic epitopes it appears 
unlikely from these data that a restricted TCR-V~ chain usage will be a general 
characteristic of thyroiditogenic T cells. 
5. 2 INTRODUCfiON 
The issue whether pathogenic autoreactive T cells utilize restricted or 
multiple TCR V genes has been intensely debated in autoimmune thyroid disease 
as in other autoimmune syndromes (Cooke, 1991; Gold, 1994; Kono and 
Theofilopoulos, 1993). TCR analysis of ITL in GO has been reported to yield 
evidence for (Davies et al., 1991; Davies et al., 1992; Davies et al., 1993) or against 
(Mcintosh et al., 1993; Caso-Pelaez et al., 1995) oligoclonal expansion, whereas no 
restriction in Va or V~ TCR genes has been observed among ITL of patients with 
HT (Davies et al., 1993). Several parameters may contribute to such apparent 
discrepancies from different studies, including diverse etiology of disease, 
determinant selection effects by various MHC alleles and the presence of non-
specific inflammatory T cells in the thyroid infiltrate. 
Similar contrasting findings have been obtained in animal models of EAT. 
NOD mice developing spontaneous thyroiditis were reported to exhibit a thyroid 
T-cell infiltrate biased towards the use of a single TCR V~ gene family, but there 
was no consistent use of a single TCR V~ chain among the various animals tested 
(Matsuoka et al., 1993). On the other hand, considerable heterogeneity of TCR 
V~ was found in thyroid-derived CD4+ T cells of mice developing "spontaneous" 
EAT, following protocols that are likely to eliminate regulatory T-cell subsets 
(Sugihara et al., 1993). 
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Even in the well-controlled model of Tg-induced EAT, variable conclusions 
have been drawn from the analysis of intrathyroidal TCR VJ3 profiles. The 
detection of 10 VI3 gene families of the 17 tested in the thyroid infiltrates of 
CBA/J mice challenged with human Tg (HTg) was presented by Matsuoka et al. 
as evidence for an early oligoclonal T-cell expansion (Matsuoka et al., 1994). In 
contrast, following the adoptive transfer of EAT in CBA mice with MTg-specific 
spleen cells, McMurray et al., (1996) reported the intrathyroidal expression of up 
to 12 TCR VI3 families as evidence for recruitment of polyclonal T cells in EAT. 
In such studies, it remains unclear whether the TCR V gene diversity among m 
reflects the recognition of multiple Tg epitopes or is an outcome of a response to 
a limited number of pathogenic peptides. Furthermore, many variables such as 
the antigen used, the method of EAT induction, the time of sampling, the choice 
of PCR primers and/ or the method of detection may influence the results. 
Since TCR V~ gene families have not yet been assigned toT-cell clones that 
recognize defined pathogenic Tg epitopes, we have examined in this report the 
TCR VI3 diversity among clonal T cells responding to a single thyroiditogenic 
peptide-MHC class II complex. As a model antigen we have used the AS-
restricted, 9mer MTg peptide (2496-04) that has been previously shown to 
directly cause EAT in SJL mice in the presence of adjuvant (Chapter 4, section 4. 
3. 5). Due to a genomic deletion, the SJL strain lacks the V~ gene families 5, 8, 9, 
11, 12 and 13 (Behlke et al., 1986). The rationale was that, in this strain, a limited 
TCR V~ heterogeneity would be more easily discerned against a single 
pathogenic epitope than against the large multiepitopic MTg molecule. 
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5.3 RESULTS 
5. 3. 1 MTg(2495-11) specific LNC transfer thyroiditis ink and s haplotype mice 
Following the observation that MTg(2496-11) induced EAT in mice of k and 
s haplotype, it was decided to test whether peptide specific LNC would transfer 
thyroiditis into syngeneic recipients., LNC from mice primed 10 days earlier with 
MTg(2496-11) were boosted with the peptide in vitro and 2 x 107 cells were 
subsequently injected i. p. into syngeneic recipients. Thyroids from all the 
recipient mice (three from each of the strains C3H and SJL) showed high degree 
of infiltration by MNC (Table S. 1). In the control group that received equal 
numbers of con A-activated splenocytes obtained from normal mice, no 
infiltration was observed in their thyroids (Table 5. 1). Adoptive transfer of EAT 
by MTg(2495-11)-specific cells clearly highlighted the importance ofT cells in this 
model and further raised the question whether the TCR on these effector cells are 
of high or low variability in nature, since TCR of limited variability would allow 
testing of future strategies aimed at intervention in the development of EAT. 
5. 3. 2 MTg(2495-11)-specificT-cell hybrids express multiple TCR-V~ genes 
In earlier studies it was revealed that Mfg(2495-11) was thyroiditogenic in 
C3H, B10. BRand SJL mice. To ascertain the TCR variability in MTg(2495-11)-
specific cells in H-2k mice, attempts were made to establish hybridomas in CBA, 
BlO. A(4R) and BlO. BR mice. Following the fusion of LNC from CBA mice, 112 
microwells were plated, out of which 18 wells showed hybridoma growth. After 
screening six hybrids, one hybrid (3Fl) was found to be peptide-specific (Figure 
5. 1) and was cloned. Subsequent to the fusions involving cells from peptide-
Table 5.1 MTg(2495-11)-specific LNC transfer thyroiditis 
Group Mouse Cultured Infiltration Index Mice 
strain in vitro with with 
MTg(2495-11) con A 0 0.5 1 2 3 EAT 
1. C3H + 0 2 1 3/3 
2. SJL + 0 1 4 5/5 
3. C3H + 3 0/3 
For EAT induction adoptive transfer of 2 x to7 peptide-specific cells was carried out as described in 
Materials and Methods. Fourteen days after cell transfer, thyroid glands were collected for 
histological examination. 
0: 
1\.) 
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primed BlO.A(4R) and BlO.BR mice, 576 and 614 microwells were seeded 
respectively. After screening, one out of nine hybrids from BlO. A(4R) and ten 
out of eighteen hybrids from BlO. BR mice were found to be MTg(2495-11)-
specific (Figures S. 2 and 5. 3). The screening data on C3H mice-derived 
hybridomas are presented in chapter 4 section 4. 3. 1. 
Flow cytometric analysis of MTg(2495-11)-specific T-cell hybridomas was 
performed using Vj3-family-specific mAbs. The fusion partner BW 5147 TCR aj3 -
cell line served as negative control. The results of Vj3 analysis ofT-cell hybrids 
from B10.A(4R), C3H, BlO. BR and CBA mice are presented in Table 5. 2. All 
hybrids responded specifically to MTg(2495-11) presented by TA3 cells (APC) 
that express Ek and Ak class II molecules. Interestingly, all three Ak_restricted 
clones 7 AlO, 4B7 and 4A12 were found to express TCR-Vj3 8.2 family genes 
whereas TCR-Vj3 6, 4 and some yet other unknown families were expressed 
among the Ek-restricted hybrids. Additional evidence on TCR-Vj3 gene usage 
among clones specific to the Ek-restricted thyroiditogenic epitope (2496-04) has 
been sought and is presented later in this chapter (see sectionS. 3. 6). 
S. 3. 3 AS-restricted T-cell epitopes within MTg(2495-11) are identical to 
the of Ek I Ak_ restricted epitopes 
From our earlier findings on epitope mapping within MTg(2495-11) 
(Chapter 4, section 4. 3. 4) it became clear that two distinct overlapping T-cell 
determinants exist within MTg(2495-11). Further, the Ek-restricted T-cell 
determinant (2496-04) could induce AS-restricted T-cell responses and thereby 
mediate thyroiditis in SJL mice (section 4. 3. 5). These data on presentation of the 
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derived from CBA/J mice. Using TA3 cells as APC, peptide-specific 
activation of the T-cell hybrids was assayed by their IL-2 release which 
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Materials and Methods. Data represent mean cpm values of triplicate 
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Figure 5. 2 MTg(2495-11)-specific screening ofT -cell hybridomas derived 
from BlO. A(4R) mice. Using TA3 as APC, peptide-specific activation of 
the T-cell hybrids was assayed by their IL-2 release which in turn was 
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Figure 5. 3 MT g(2495-11 )-specific screening of the T -cell hybridomas 
derived from BlO.BR mice. Using TA3 (APC), peptide specific activation of 
T-cell hybrids was assayed by their IL-2 release which in turn was assessed 
by proliferation of CTLL-2 as described in Materials and Methods. Data 
represent mean cpm values of triplicate wells. SO values were < 10% of the 
means. 
TableS. 2 Multiple TCR-V~ gene usage by MTg(2495-11)-specific T-cell hybridomas 
Mouse 
strain 
B10.A(4R) 
C3H 
BlO.BR 
CBA 
T cell a 
hybrid 
7A10 
4B7 
4A12 
4A2 
8C8 
8F9 
8H9 
8Cl 
3Ft 
CTLL proliferation (c.p.m.) 
Cloning MHC-
status restriction MTg(2495-11) medium 
1-Ak 90,626 1,070 
+ 1-Ak 43,265 417 
+ 1-Ak 36,111 407 
+ 1-Ek 29,437 244 
ND 18,019 570 
ND 23,841 845 
1-Ek 23,781 815 
1-Ek 26,161 787 
+ 1-Ek 46,530 332 
v~ 
family 
8.2 
8.2 
8.2 
6 
14 
14 
7 
7 
4 
------------------------------------------------------------------------------
+: cloned, -: uncloned, ND: not done 
Peptide-specific response and MHC-restricition data of hybrid clones 4A12 and 4A2 have been discussed 
earlier (see Chapter 4, section 4. 3. 2). MHC-restriction of the remaining T -cell hybrids was similarly 
detennined in mAb-blocking assays using class 1- (K and D) and class II (A and E moJecuJes)-spedftc mAb as 
described in Materials and Methods. Phenotyping for TCR-V~ gene expression was done using mAb 
specific for 2, 3, 4, 5, 6, 7, 8.1/.2/.3, 9, 11, 13, 14 and 17 TCR-V~ families. All hybrids were stained positive 
with anti-TCRa~FITC conjugate. 
(X) 
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T -cell determinant (2496-04) by non-isotypic class IT molecules prompted further 
studies on localizing epitopes within MTg(2495-11) recognized by SJL T cells. 
The objective was to determine if more than one AS-restricted T-cell epitope(s) 
exists within MTg(2495-11) and whether they map distinctly from Ek -/ Ak 
-restricted epitopes. 
To establish peptide-specific clonaLI.rells,. SIL mice were primed with the 
MTg(2495-11} in CFA and aT-cell fusion was performed as described in Materials 
and Methods (section 3. 3. 1}. Following the fusion, a total of 768 microwells were 
seeded; 563 showed hybridoma growth; and finally 11 hybrids were screened for 
their peptide-specific response (Figure 5. 4). Of those specific to the immunizing 
peptide, two randomly selected hybrids, 5H3 and 5E8 were cloned. Two 
representative clones namely 5H3.18 and 5E8.9, one from each hybrid, were 
further selected for epitope mapping studies. In blocking experiments using anti-
AS mAb, both clones were characterized to be peptide-specific and AS-restricted 
(Figure 5. 5). 
Subsequently, in epitope mapping studies clones 5H3.18 and 5E8.9 were 
tested against a peptide panel (Figure 5. 6) consisting of the MTg(2495-11) 
sequence (pep. 1) and 13 shorter peptides truncated by one a. a. at the N-terminal 
(peptide no. 2-6) or the carboxyl terminus (peptide no. 7-14) of MTg(2495-11). LS 
102.9 cells were used as APC and final peptide concentration was kept constant 
at 10 J..Lg/ml. The reactivity of the 5H3.18 clone was lost upon the removal of the 
Leu2496 at the N-terminal (pep. 3). Peptides further truncated of their N-
terminal residues (i.e., pep. 4-6) were clearly non-stimulatory. The response 
against pep. 6 was marginally higher than the cut-off value which is background 
mean cpm + 2 SD). When tested against a second set of peptides with truncations 
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Figure 5. 4 MTg(2495-11)-specific screening T-cell hybridomas derived 
from SJL mice. Using LS 102.9 (APC), peptide-specific activation of the 
T-cell hybrids was assayed by their IL-2 release which in turn was 
assessed by proliferation of CTLL-2 as described in Materials and 
Methods. Data represent mean cpm values of triplicate wells. SD values 
were< 10% of the means. 
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Figure 5. 5 mAb-mediated blocking of MTg(2495-11)-specific activation of the cloned T-cell hybridomas 
5H3.18 and 5E8.9. In triplicate wells, 1cf T cells and equal number of l.S 102.9 cells (APC) were cultured 
with MTg(2495-11) (10 J.Lg/ml) and the indicated anti-if mB 92) or anti-NP (HB 65). The concentration of 
IL-2 in the supernatant was assessed by the proliferation of the IL-2-dependent CfLL line. Background cpm 
means in the absence of antigen were 5H3.18 = 864 and 5E8.9 = 848. 
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Peptide 5H3.18 51:8.9 
No. 2495 2503 2511 
I I 
1. GLINRAKAVKQFEESQG 
2. L I N R A K A V K Q F E E S Q G 
3. I N R A K A V K Q F E E S Q G 
4. N R A K A V K Q F E E S Q G 
5. R A K A V K Q F E E S Q G 
6. A K A V K Q F E E S Q G 
7. G L I N R A K A V K Q F E E S Q 
8. G L I N R A K A V K Q F E E S 
9. G L I N R A K A V K Q F E E 
1 0. G L I N R A K A V K Q F E 
11. GLINRAKAVKQF 
12. G L I N R A K A V K Q 
13. GLINRAKAVK 
14. GLINRAKAV 
0 2 4 6 0 120 
3[H] .. thymldlne uptake (cpm x 103) 
Figure 5. 6 Mapping ofT cell epitopes within MTg(2495-11) using SJL T cell hybrids 5H3.18 and 5E8.9. 
LS 102.9 cells were used as APC and all the peptides were kept at a final concentration of 10 ~g/ml. 
Data represent means of triplicate cpm values of proliferating CfLL and reflect the relative IL-2 content 
of supernatants during T-cell activation. S.D values were <10% of the means. The standard single letter 
code is used to designate amino add residues. In the presence of medium alone background cpm were 
5H3.18 = 527, 5E8.9 = 1706. Dotted line shows the cut-off value (background mean+ 2 SD) for the 
activation of the hybrid. 
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in their C-terminal residues (pep. 7-14), the response of the SH3.18 hybrid was 
lost upon removal of Lys2504 at the carboxyl terminus (pep. 14) (Figure 5. 6). 
These data delineated the 5H3.18 recognizing determinant by Leu2496 and 
Lys2504, a 9mer epitope (2496-04) that is identical to the one mapped earlier by 
Ek..restricted 4A2 clone (Chapter 4, section 4. 3. 3). On the other hand, removal 
of theN-terminal Arg2499 (pep. 6) or the C-terminal Glu2507 (pep. 11) abolished 
the activation of the 5E8.9 clone, revealing the presence of a second 9mer T-cell 
epitope (2499-2507) (Figure 5. 6), identical to the one mapped previously by the 
Ak..restricted 4A12 hybrid clone. 
5. 3. 4 Lack of generation of MTg(2496-04) T-cell epitope from Tg processing 
byAPC 
Previous work in our laboratory revealed that, in H-2k mice, MTg(2495-11) 
could not induce MTg- or RTg- reactive LNC-proliferative responses and vice 
versa i.e., priming mice with either Tg failed to induce peptide-reactive LNC-
proliferative responses (Chronopoulou and Carayanniotis, 1992). In the present 
study, MTg(2495-11)-specific SJL hybrid clone 5E8.9 was used to examine 
whether MTg or RTg processing by APC in vitro would generate the peptide. The 
rationale was that the 5E8.9 hybrid, being a highly sensitive clone responding to 
nM concentration of its peptide-ligand on LS 102.9, would detect (2495-11) 
following Tg processing. Equal number of the hybrid T cells and APC were 
cultured for 24 h in the presence of 0.07 to 0.3 !1M concentration of MTg(2495-ll), 
mouse or rat Tg. The results presented in the Table 5. 3 clearly suggested that 
the epitope in question was not a product of APC processing of mouse or rat Tg. 
As assayed by CTLL-2 proliferation, the clone did not respond to LS 102.9 pulsed 
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Table 5. 3 The MTg(2495-11) peptide is not generated during Tg processing 
by LS 102.9 cells 
Antigen 
in culture 
MTg(2495-11) 
MTg 
RTg 
MTg(2695-13) 
(control Ag) 
CTLL-2 proliferation (c p m x to-3) • 
Ag concentration (J.LM) 
0.30 0.15 0.07 
133.17 ± 12.23 130.52 ± 6.06 111.12 ± 8.62 
0.43 ± 0.02 0.62± 0.14 0.67± 0.19 
0.92± 0.68 0.59± 0.31 0.70± 0.23 
0.68± 0.27 0.45± 0.23 0.53± 0.09 
105 LS 102.9 cells and an equal number of hybrid cells were cultured with above 
mentioned antigens at the indicated concentrations. Culture supernatants after 
24h, were assayed for their IL-2 content using CTLL-2 as described in Materials 
and Methods. 
•nata represent mean cpm ± SD of triplicate wells. Background c. p.m. (no 
added antigen in culture)= 511. 
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with MTg or RTg but mounted a strong response to LS 102.9 plus MTg(2495-11) 
peptide added at all the three doses (Table 5. 3). Therefore, these findings 
confirm the view that the MTg(2495-11) is a site of cryptic T-cell determinants. 
5. 3. 5 MTg(2496-04) peptide constitutes a minimal T-cell determinant 
To determine whether LINRAKA VI< is a minimal T-cell epitope in SJL 
hosts, inguinal LNC from mice challenged with this epitope were tested for their 
proliferative capacity against a panel of truncated peptides from the 
immunopathogenic 17mer (2495-11) sequence. As shown in Table 5. 4, loss of 
Leu2496 or Lys2504led to a diminished proliferative response, delineating the a. 
a. (2496-04) as the coordinates of a minimal T-cell epitope in H-2s mice. These 
findings are in agreement with our previous studies that described (2496-04) as a 
minimal epitope recognized by Ek..restricted T -cell hybrids derived from C3H 
mice (Chapter 4, section 4. 3. 3) and also by AS-restricted T-cell hybrids from SJL 
hosts (Figure 5. 6). Amino acids Leu2496 and/or Lys2504 may play an important 
role for peptide binding to AS or they may act as key TCR-contacting residues. 
5. 3. 6 MTg(2496-04) activates Thl cells 
To ascertain the cytokine profile ofT cells responding to MTg(2496-04), 
inguinal LNC, from SJL mice primed ten days earlier with this epitope, were 
cultured for 72 hr in the presence of MTg(2496-04) or the 17mer MTg(2495-11). 
The culture supernatants were then assayed for IL-2, IFN-y and IL-4. As shown in 
Figure 5. 7, both peptides induced the release of IL-2 from specific T-cells which 
was approximately 4-9-fold higher than that observed in control supernatants 
(medium alone). Similarly, IFN-y was easily detectable (8.5-11.5 ng/ml} upon 
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Table 5. 4 MTg(2496-04) constitutes a minimal T-cell epitope 
Proliferati~a LNC-response,. (cpm) 
Antigen 
in vitro Mean ± SD (5. I.) 
GLINRAKA VKQFEESQG 57, 115 ± 617 (11.35) 
LINRAKAVK 80,057 ± 6,666 (19. 82) 
INRAKA VKQFEESQG 10,372 ± 1,328 (2. 57) 
NRAKA VKQFEESQG 6, 059 ± 159 (1. 50) 
GLINRAKAVK 85, 055 ± 4, 184 (21. OS) 
GLINRAKAV 6, 146 ± 1, 011 (1. 52) 
*Recall in vitro assay of inguinal LNC from SJL mice primed s. c. at the base 
of the tail with SO nmol MTg(2496-04) in CFA ten days earlier, and tested 
against the indicated peptides (10 JJ.g/ml final concentration). Background 
cpm ± SD (no added antigen in culture) varied from 4, 040 to 5, 030. 5. I. 
values > 3 are considered significant and are underlined. 
Bold letters denote the a.a. residues of the priming peptide. 
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0 4 8 12 0 
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4 8 
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Figure 5. 7 Determination of IL-2, IFN-y and IL-4 in the culture supernatants of 
MTg(2496-04)-primed LNC. Ten days after priming, inguinal LNC were cultured in 
the presence of 10 J.Lg/ml of peptide MTg(2496-04) or MTg(2495-11) for 72 h. Relative 
IL-2 content was assessed by the proliferation of the IL-2-dependent CTLL-2. The 
values for IFN-y and IL-4 were extrapolated from standard curves. 
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stimulation with either peptide. In contrast, IL-4 was detectable only at very low 
amounts (20-23 pg/ml) in the same cultures. These results strongly suggested 
that the MTg(2496-04) epitope induces Th1 cells. 
5. 3. 7 Multiple TCR-Vl3 gene usage by T -cell hybridomas specific for the 
minimal MTg-epitope: (2496-04) 
To sample the Vl3 gene expression among the MTg(2496-04)-specific Th1 
cells in the above cultures, we proceeded to generate a panel of T -cell hybrid 
clones from two independent fusions between BW5147a-l)- and peptide-specific 
proliferating LNC. A total of 21 hybrids (out of 82 tested) were found to be 
peptide-specific and were preserved. MTg(2496-04)-reactive, IL-2 secreting 
clones representing five randomly selected positive hybrids from each fusion 
were further tested for their gene expression by RT-PCR (Table 5. 5). Out of ten 
hybrids analyzed, five clones expressed Vl3 2, three expressed Vl3 4, and two 
were positive for Vl3 17. 
The amplification products from the eDNA of three representative T -cell 
clones, 9-32.1, 9-13.6, and 10-25.2 expressing Vl3 2, Vl3 4 and Vl3 17, respectively, 
are shown in Figure 5. 8. For each clone, only a single Vl3 product was amplified 
using primers for each of the 12 SJL Vl3 families tested. All Vl3 primers yielded 
detectable PCR products of the expected size when mRNA from SJL splenocytes 
was analyzed by RT-PCR (data not shown). These findings clearly show the 
presence of multiple Vl3 genes in the MTg(2496-04)-specific TCR repertoire and 
suggest that Vl3 2, 4 and 17 are predominantly utilized by IL-2 secreting Th1 cells 
that recognize this pathogenic epitope in SJL hosts. 
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Table 5. 5 TCR-VI3 gene usage by MTg(2496-04)-specific hybrid T cell clones 
CTLL-2. proliferation (cpm) • 
Tcell 
Fusion hybrid MTg(2496-04) medium vp family t 
I 9-13.6 46,608 383 4 
9-2.4 92,903 1,407 2 
9-6.10 63,223 312 17 
9-32.1 115,115 7,092 2 
9-5.1 5,875 349 2 
II 1D-1.6 69,563 3,931 2 
1D-19.1 49,194 2,862 4 
1D-25.1 33,701 307 17 
10.26.1 20,160 187 4 
10.28.1 30,184 737 2 
• Data represent mean cpm of duplicate wells. SD values were < 20% of 
mean values. 
t TCR Vj3-family gene expression was detf'..rmined by RT-PCR as 
described in Materials and Methods. Due to ger,etic deletions SJL mice do 
not express V~, 8, 9, 11, 12 and 13 gene families (Behlke et al., 1986). 
Hybridoma 
9-32.1 
9-13.6 
10-25.2 
99 
VB families Jm 
c 1 2 3 4 6 7 10 14 15 16 17 18 
.... suo 
.... suo 
.... 400 
.... 600 
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.-&DO 
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.... 400 
Figure 5. 8 Determination of TCR-Vj3 gene expression in MTg(2496-04) specific 
T-cell hybridoma clones by RT-PCR. Data from three representative clones 9-32.1, 
9-13.6 and 10-25.2 showing expression of TCR-Vj3 2, 4 and 17 respectively, are 
shown. C = GADPH control. 
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5. 4 DISCUSSION 
The present data demonstrate for the first time in the field of EAT, the 
recruitment of multiple TCR Vl3 genes in the recognition of a defined 
thyroiditogenic epitope. In SJL mice, which express only one functional MHC 
class II molecule, AS, the utilization of three (i.e. 2, 4 and 17) out of twelve 
available Vl3 families for the recognition of a single peptide-MHC complex is 
compatible with results from other EAT studies (Matsuoka et al., 1994; 
McMurray et al., 1996; Nakashima et al., 1996) showing involvement of many Vl3 
families in the response to the multiepitopic Tg molecule (Carayanniotis and Rao, 
1997). Since the MTg(2496-04) epitope also binds to the non isotypic Ek molecule 
in H-2k mice (Chapter 4), and the MHC haplotype is known to affect the 
thyroiditogenic TCR repertoire (Lomo et al., 1996), it is likely that T cells 
expressing other Vl3 families in addition to 2, 4 and 17 may be involved in the 
recognition of this epitope at the population level. The use of three different 
TCR-VI3 gene familes (VI36, 4 and some unknown) by the Ek-restricted 
MTg(2495-11)-specific hybrids derived from C3H, CBA and B10. BR mice (with 
differing non-MHC background) also tends to support this view. 
Because homing of lymphocytes to the thyroid gland can be influenced by 
many parameters (Weetman and McGregor, 1994), and the approach we have 
followed here selects only for IL-2-secreting MTg(2496-04)-specific T cells, we 
cannot exclude the possibility that the intrathyroidal TCR Vl3 profile may not be 
identical to that observed in peripherally derived peptide-specific clonal T cells. 
In that regard, it has been hypothesized that selective expansion of intra thyroidal 
T cells may occur via mechanisms such as recognition of self-MHC or 
superantigen-like molecules (Davies, 1995). On the other hand, the assessment of 
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intrathyroidal TCR V genes can be complicated due to the presence of aberrant 
thymus tissue in the thyroids of 20-60% of mice from several inbred strains 
including CBA/J and SJL/J (Dunn et al., 1961; Vladutiu and Rose, 1972a). Unlike 
other organs targeted by autoimmune responses, the normal thyroid contains 
discrete masses of lymphoid tissue, that could lead to detection of many TCR V 
gene families that are unrelated to those used by pathogenic T cells. To date, this 
issue has not been adequately addressed in EAT studies that have focused on the 
assessment of intra thyroidal TCR V genes. 
It remains to be seen whether T -cell subsets responding to other known 
pathogenic Tg epitopes (Carayanniotis and Rao, 1997) will similarly express 
multiple V~ genes. In other autoimmune models, evidence for (Karin et al., 1993) 
or against (Su and Sriram, 1992; Bell et al., 1993; Kuchroo et al., 1992; Sobel and 
Kuchroo, 1992) limited TCR V gene usage has been reported for individual 
pathogenic peptides. All known pathogenic Tg epitopes, including the 9mer 
MTg(2496-04) used here, have been defined as non dominant (Carayanniotis and 
Rao, 1997) but, in general, multiple TCR V~ genes can be recruited in the 
recognition of either cryptic or dominant epitopes (Kono and Theofilopoulos, 
1993). 
Non dominant but pathogenic Tg epitopes must be generated 
intrathyroidally to allow for specific homing of effector T cells. Anti-TCR based 
immunotherapy aimed at eliminating these cells could be potentially beneficial 
because it takes into account: a) the spreading of autoaggression from dominant 
to cryptic epitopes during the course of disease (Lehmann et al., 1993), and b) 
potential triggering of the autoimmune response by cryptic epitopes per se. e.g. 
via molecular mimicry with other determinants of microbial or self origin 
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(Oldstone, 1987). However, the documented involvement of multiple TCR V 
genes among min autoimmune thyroid disease (Davies et al., 1993; Mcintosh et 
al., 1993; Caso-Pelaez, 1985}, among Tg-specific T cells in EAT (Matsuoka et al., 
1993; Sugihara et al., 1993; Matsuoka et al., 1994; McMurray et al., 1996}, and in T 
cells responding to a single pathogenic Tg epitope as shown in the present study, 
argue against the practicality ofTCR-based immtmotk\:.rapyin thyroid disease. 
CHAPTER 6 
CONTRASTING IMMUNOP A THOGENIC PROPERTIES OF HIGHLY 
HOMOLOGOUS PEPTIDES FROM MOUSE AND HUMAN 
THYROGLOBULIN 
6.1 SUMMARY 
The current lack of a. a. sequence data for MTg necessitates mapping of 
pathogenic T-cell epitopes on heterologous Tgs in mouse EAT. A prevailing 
assumption has been that epitopes sharing a high degree of a. a. homology 
among heterologous Tgs are likely to exhibit the same immunopathogenic 
properties in the same host. In this chapter, I have examined this concept while 
working with a non dominant 18mer MTg(2695-13) peptide that was previously 
shown to elicit AS-restricted T cells and EAT in SJL mice. A major 
immunopathogenic T-cell epitope was localized within the 12mer MTg(2695-06). 
It was found that the human 12mer homologue carrying two Ser substitutions at 
Gln2703 and Thr2704 exhibited contrasting properties: a) it failed to activate Thl 
cells in lymphokine and proliferation assays, b) it did not cross react with 
MTg(2695-06) at the T-celllevel and c) it induced only focal thyroiditis following 
adoptive transfer of specific LNC. These data highlight caution against 
extrapolating results of pathogenic T-cell epitope mapping across heterologous 
Tgs, even when such epitopes share a high degree of a. a. homology. 
Some the results presented in this chapter have been published as: 
i) Carayanniotis, G., Chronopoulou, E. and Rao, V.P. (1994). Distinct genetic pattern of mouse 
susceptibility to thyroiditis induced by a novel thyroglobulin peptide, Inununogenetics 39,21-28 
ii) Rao V.P. and Carayanniotis G. (1997). Contrasting immunopathogenic properties of highly 
homologous peptides from rat and human thyroglobulin, Immunology 90, 244-249. 
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6. 2 INTRODUCTION 
From studies that span the last four decades, it has been clearly shown that 
Tg, the most abundant antigen of the thyroid gland and the largest autoantigen 
known (homodimeric mol. mass = 660 kD), induces EAT, aT-cell mediated 
disease (Charreire, 1989; Rayner et al., 1993; Kong, 1994; Weetman and 
McGregor, 1994). In the mid-1980s, eDNA sequencing showed that the HTg and 
BTg consist of 2748 and 2750 a. a. residues respectively (Malthiery and Lissitzky, 
1987; Mercken et al., 1985) and partial sequencing of the RTg gene delineated the 
last 967 a. a. at the C-terminal end (DiLauro et al., 1985). These studies revealed 
that, despite the enormous molecular size, Tgs from various species were 
evolutionarily conserved. For example, more than 77% of the a. a. residues in BTg 
and HTg are identical and more than 6% are conservative substitutions. 
In recent years, efforts to map pathogenic Tg T-cell epitopes in mouse EAT 
(Hutchings et al., 1992; Texier, 1992; Chronopoulou and Carayanniotis, 1992; 
Carayanniotis et al., 1994; Hoshioka et al., 1993; Kong et al., 1995) utilized the a. a. 
sequences of heterologous T gs, since the a. a. sequence of MT g remains 
unknown. A central assumption has been that heterologous pathogenic Tg 
epitopes would be easily identified because they would probably be themselves 
phylogenetically conserved and, therefore, their a. a. sequence would be identical 
to or very similar with pathogenic MTg determinants. This assumption seems 
plausible in view of the success of these early efforts but it does not take into 
account that limited a. a. substitutions at key residues contacting either the MHC 
or TCR can exert profound changes in the immunogenic properties of peptides 
(Windhagen et al., 1995; Evavold et al., 1993; Sette et al., 1994; Suhrbier, 1991). In 
addition, this assumption fails to explain the contrasting immunopathogenic 
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profiles of heterologous Tgs in mice. For example, BTg induces strong 20 
proliferative LNC responses but no direct thyroid pathology in CBA mice 
(Romball and Weigle, 1984), whereas RTg and HTg induce both EAT and 
considerable LNC proliferation in the same strain (Charreire, 1989; Romball and 
Weigle, 1984; Simonet al., 1985). 
To,tha..extent that these findings remain poorly understood at the molecular 
level, we sought, in the present study, to investigate the immunopathogenic 
properties of a HTg peptide sharing high homology with the AS-restricted 18mer 
MTg (2695-13) sequence that was previously shown to induce EAT in SJL hosts 
(Carayanniotis et al., 1994). Our aim was to examine whether a limited number 
of a. a. substitutions across heterologous Tg epitopes would lead to large 
differences in thyroiditogenicity, a concept that has not so far been tested in the 
field of EAT. The results have important implications in the strategies devised to 
map pathogenic determinants in Tg. 
6. 3 RESULTS 
6. 3.1 Characterization of MTg(2695-13)-specific AS-restricted T-cell hybrids 
Following in vivo priming, with MTg(2695-13) only mice of s haplotype 
developed thyroiditis. To further characterize the T-cell determinant(s), that are 
possibly responsible for inducing EAT, MTg(2695-13)-specific donal T cells were 
generated in the form ofT-cell hybridomas from a fusion between TCR cx~­
BW5147 and peptide-specific lymph node blasts as described earlier (see section 
3. 3. 1). Out of eight hundred and eight wells seeded, forty showed hybridoma 
growth. As shown in the figure 6. 1 eleven out of twenty three hybridomas 
screened were found to be specific for MTg(2695-13). Out of these, hybrids 6E10 
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Figure 6. 1 MTg(2695-13)-specific screening ofT-cell hybridomas derived from 
SJL mice (A & B). LS 102.9 were used as APC. Peptide (10 J..Lg/ml)-specific 
activation ofT cell hybrids was assayed by their IL-2 release which in turn was 
assessed by proliferation of CTLL-2. Data represent mean cpm values of 
triplicate wells. SD values were < 10% of the means. 
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screened were found to be specific for MTg(2695-13). Out of these, hybrids 6E10 
and 609 were selected and cloned. FACS analysis revealed that clone 6El0.8 
(derived from 6E10 hybrid) was CD4+, CDS- and TCR a~+ (Figure 6. 2A). From 
mAb blocking experiment (Figure 6. 28) it was clear that within MTg(2695-13) 
the epitope recognized by 6E10.8 was AS-restricted since anti-AS mAb (but not 
control Ab) inhibited the activation of hybridoma as assessed by IL-2 content of 
the culture supernatant. 
6. 3. 2 MTg(2695-13) is not a product of in vitro processing of Tg by APC 
It has also been speculated that for pathogenic effector cells to home to, and 
persist in the target organ they should be able to recognize specific antigen in 
that microenvironment. Since the immunization of mice with MTg(2695-13) in 
adjuvant induces thyroiditis in SJL hosts, it raised the possibility that the above 
peptide might be generated out of processing of Tg by APC- a property that is 
often shared by immunodominant peptides. To test if the MTg(2695-13) 
epitope(s) is expressed in association with class II molecules, LS 102.9 (APC) and 
6E10 hybrid T cells were incubated in the presence of mouse or rat Tg. As shown 
in Figure 6. 3A the T-cell hybridoma responded strongly to MTg(2695-13) but 
not to the control peptide (MTg(2495-11) in the range of 0.3 - 0.07 J.LM. 
Interestingly, however, the 6E10 hybrid T-cell clone did not respond to the 
equimolar concentrations (i.e., 0.30, 0.15 and 0.07 J.LM) of MTg or RTg, a result 
compatible with the lack of presentation of MTg(2695-13) epitope(s) in the 
context of AS-molecules (Fig 6. 3A). As APC are known to differ in the 
generation and presentation ofT -cell epitopes (Vidard et al., 1992 and Sun et al., 
1993), we asked if other APC such spleen cells could present the epitope in 
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Figure 6. 3D The MTg(2695-13) is not generated during Tg 
processing by splenocytes.1 O~tomycin-C treated syngeneic 
splenocytes and 1 o5hybrid T cells were incubated in the presence of 
indicated concentrations of the antigens. Data represent means of 
triplicate cpm values of proliferating CTLL and reflect the relative 
IL-2 content of the culture supenatants following T cell activation. 
Backgound (6E10 plus spleen cells alone) cpm were = 524. 
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Figure 6. 3A The MTg(2695-13) is not generated during Tg processing by 
LS102.9. CTLL proliferation as an index of IL-2 release (mean c. p.m. of 
triplicate wells) by the MTg(2695-13)-spedfic T-cell hybrid 6E10, in the 
presence of the indicated Ag. Backgound c.p.m. (6E10 plus LS 102.9 
alone) were = 230. 
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question. To test this, mitomycin-C treated SJL splenocytes were incubated with 
MTg and RTg as described earlier and used in the hybridoma activation assays. 
Activation of the clone by MTg(2695-13) but not MTg(2495-11) in all doses 
employed, confirmed the specificity of the clone and showed that mitomycin-C-
treated splenocytes were competent APC. MTg(2695-13) is not a product of Tg-
processing because of lack of activation of the clone by Tg at 0.3 and 0.15 ~ 
concentrations, at which the peptide was clearly stimulatory (Figure 6. 38). 
6. 3. 3 Lack of T-cell cross-reactivity between homologous Tg epitopes 
RTg and HTg are phylogenetically conserved proteins with 74.5% of their a. 
a. being identical and 7.14% conservatively substituted (Malthiery and Lissitzky, 
1987). Intact RTg and HTg elicit strong cross-reactive proliferative LNC 
responses in mice (Table 6. 1), a phenomenon that is explained on the basis of 
shared T -cell epitopes. It was decided to examine if high a. a. homology between 
heterologous Tg peptides would be also predictive of similar immunogenic 
properties by comparing the known pathogenic MTg(2695-13) peptide 
(Carayanniotis et al., 1994) with its human analogue which is approximately 79% 
identical and carries 3 a. a. substitutions at positions 2703 (Q -> S), 2704 (T-> S), 
2707 (D -> T) and one insertion (S) at position 2708 (Figure 6. 4). It was found 
that LNC from SJL mice primed with the mouse Tg peptide did not recognize the 
human analogue in vitro (Table 6. 1). Furthermore, the HTg(2695-13) peptide 
failed to prime SJL mice for a proliferative LNC response against itself (Table 6. 
1). The lack of antigenicity and immunogenicity in a human peptide highly 
homologous to a pathogenic site of MTg prompted us to investigate the T-cell 
site(s) responsible for this contrasting response. 
Table 6. 1 Lack of immunogenicity and antigenicity of the HTg(2695-13) 
Antigen"' Proliferative LNC response in vitro (S. I.+/~ S.D.) against t 
In vivo In vitro (~g/ml) RTg HTg MTg(2695-13) HTg(2695-13) 
RTg 10 li!J. M 1.0 1.0 
2.5 8.5 ~ 1.0 0.9 
HTg 10 4.8 ~ 1.1 1.0 
2.5 u ZJi 1.1 1.1 
MTg (2695-13) 10 M 1.1 
2.5 5.& 1.0 
HTg (2695-13) 10 1.5 1.5 1.3 1.2 
2.5 1.0 1.0 1.1 1.1 
"'Two mice per group were challenged with 50 ~g of RTg or HTg or 50 nmol of MTg(2695-13) 
HTg(2695-13) in CFA. Ten days later, inguinal LNC were allowed to proliferate against the above 
indicated Ag as descibed in Materials and methods. 
t S.l. values > 3 are considered significant and are underlined. Background cpm (cultures with no 
added Ag) were RTg = 13,144, HTg = 16,943, MTg(2695~13) = 1,052 and HTg(2695-13) = 3,992. In 
all experiments, a strong proliferative response was observed against PPD @ 10 ~g/ml (not 
shown). 
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Figure 6. 4 Alignment of the pathogenic MTg(2695-13) sequence with its 
human homologue. Open box shows identical a.a. (79%), shaded box shows 
conserved a. a. substitutions, and....,. indicates a. a. insertion. Numbers 
indicate relative positions within the HTg sequence. 
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6. 3. 4 Mapping of T-cell determinants within MTg(2695-13) 
To localize T-cell epitope(s) within MTg(2695-13), we synthesized three 
overlapping 12mer peptides (2695-06}, (2698--09} and (2701-13) spanning the 
MTg(2695-13} sequence. LNC from SJL mice, primed ten days earlier with 
MTg(2695-13), responded strongly against MTg(2695-13) and the N-terminal 
(2695-06) peptide (Table 6. 2}. No response was observed against the "core" 
(2698-09) peptide and only marginal reactivity was demonstrable against the C-
terminal (2701-13) 12mer. Conversely, the N-terminal MTg(2695-06) peptide was 
dearly immunogenic in SJL mice and elicited strong LNC responses against the 
18mer MTg(2695-13) but not against the other overlapping peptides. A weak 
cross-reactive response against the (2698--09} peptide was detectable, reflecting 
the extensive a. a. sharing between these epitopes. These results delineated the 
MTg(2695-06) as the site responsible for the immunogenicity of the 18mer 
MTg(2695-13). 
Further evidence that peptide(2701-13) harbored a distinct T-cell 
determinant when MTg(2701-13)-specific clone 609 was tested against the three 
overlapping peptides. The clone 6D9 strongly responded to (2695-13} as well as 
(2701-13) but remained unreactive to (2695-06) (Figure 6. 5}. Taken together, 
these findings that 18mer MTg(2695-13} encompasses two distinct overlappingT-
cell determinants. 
6. 3. 5 Substitution of Gln2703 and Thr2704 by Ser influences 
immunogenicity of the Tg(2695-06) peptide 
We next synthesized the 12mer human analogue of MTg(2695-06) which 
carries two Ser substitutions at positions 2703 and 2704 (Figure 6. 6). SJL mice 
Table 6. 2 The Tg(2695-06) site delineates epitope(s) recognized by proliferative LNC in SJL mice 
Peptide 
in vivo a) 
LNC-proliferative response in vitro (S. 1.) against t 
(a. a.) (2695-13) (2695-06) 
CSFWSKYIQTLKDADGAK (2695-13) 10.7 12.9 
CSFWSKYIQTLK 
WSKYIQTLKDAD 
(2695-06) 
(2698-09) 
YIQTLKDADGAK (2701-13) 
1.9 1.5 
1.5 
(2698-09) (2701-13) 
1.9 2.7 
1.1 
2.0 1.7 
1.9 2.9 
* Two mice per group were s.c. primed with 50 nmol of peptide in CFA and ten days later, 
their inguinal LNC were allowed to proliferate in the presence of the indicated peptide Ag 
(20 Jlg peptide /ml) in vitro. 
t S.I. values >3 are considered significant and are underlined. Data representative of two 
experiments are shown. Standard deviations were less than 10% of the means. Background 
cpm were: (2695-13) group;;;1,052; (2695-06) group;;;1,706; (2698-09) group=4,149 and (2701-
13) group=1,135. 
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Figure 6. 5 Activation of MTg(2695-13)-specific T-cell hybrid clone 
6D9 by the C-terminal 12mer sequence (2701-13). In triplicate 
wells, equal numbers of T cells and LS 102.9 were cultured 
separetely in the presence of 10 J,lg/ ml peptide concentration. The 
data represent mean cpm values reflecting the IL-2 dependent 
proliferation of CTLL-2. Background cpm were= 1531. 
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were again primed with either the mouse or human (2695-06) peptides and, ten 
days following antigenic challenge, their inguinal proliferative LNC responses 
were assessed in vitro. It was observed that the human analogue was not 
recognized by MTg(2695-Q6)-primed LNC and, furthermore, it could not induce 
proliferative LNC responses in SJL mice (Figure 6. 6). To determine whether 
HTg(2695-06) primed non proliferative T cells, we tested .br EUSA the 
supernatants of these cultures for the presence of lymphokines. After 72 h of 
culture, MTg(2695-06)-primed T cells released highly significant amounts of IL-2 
and IFN-y in response to the rat peptide - but not to the human 12mer analogue 
(Figure 6. 7). In contrast, supernatants from HTg(2695-06)-primed LNC cultures 
contained neither of these lymphokines, regardless of the antigenic challenge in 
vitro. IL-4 was undetectable in all cultures. Lack of proliferation or lymphokine 
release by the HTg(2695-06)-primed T cells highlights the importance of Gln2703 
and Thr2704 in the recognition of MTg(2695-06) by Thl cells. 
6. 3. 6 In a homologous Tg peptide pair, a T cell clone recognizes only 
the mouse but not the human analogue 
Confirmation of the above findings from the LNC proliferation assays was 
sought at the T-cell clonal level, using the AS-restricted T-cell hybrid 6E10 that is 
specific for MTg(2695-13) (Carayanniotis et al., 1994). As shown in figure 6. SA 
the 6E10 clone secretes high amounts of IL-2 in response to MTg(2695-13) but not 
against the 18mer HTg(2695-13). Similarly, 6E10 responded strongly to the 12mer 
MTg(2695-06) but not to equimolar concentrations of HTg(2695-06) (Figure 6. 
SB). Lack of activation was demonstrable even at concentrations >100 J..Lg/ml of 
the human 12mer peptide (data not shown). These data confirmed the 
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Figure 6. 6 HTg(2695-06) does not induce proliferative T-cell responses and is 
not recognized by MTg(2695-06)-specific cells. Inguinal LNC from mice (3 
mice I group) primed s.c. with 50 nmol of MTg(2695-06) or HTg(2695-06) 10 
days earlier, were cultured for 96 h in the presence of varying concentrations 
of the indicated peptides. Data represent the S. I. values (against 50 JJ.g/ ml 
antigen concentration) of triplicate wells obtained from peptide titration 
curves. Background cpm were: MTg(2695-06) group= 5838; hTg(2695-06) 
group = 2601. 
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Figure 6. 7 Lymphokine assays of culture supernatants of LNC primed in vivo (50 nmol peptide in CPA/mouse) and restimulated 
in vitro (at 3 ~LM final peptide concentration) with the indicated combination of peptides. Data represent mean concentration 
values of IFN-y (a) and IL-4 (b) extrapolated from ELISA standard curves, constructed according to the manufacturer's 
instructions. Data for IL-2 (c) represent mean cpm reflecting 3[H]-thymidine uptake by proliferating CTLL. S.D.< 10% of means. 
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Figure 6. 8 The human homologue of MTg(2695-13) or its amino terminal12mer 
sequence (2695-06) fails to activate the T cell clone 6E10. In triplicate wells, equal 
numbers ofT cells and LS102.9 were cultured separately in the presence of 
mouse or human Tg(2695-13) (a) or mouse and human Tg(2695-06) (b). The data 
represent mean cpm values reflecting the IL-2 dependent CTLL proliferation. 
Background cpm in these experiments were 1514 in (a) and 932 in (b). 
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importance of positions 2703 and 2704 for peptide recognition by T cells 
suggesting that the serine substitutions affected either binding to MHC and/ or 
interfered with TCR contact. 
6. 3. 7 Comparison of EAT induction and IgG response by homologous 
MTg and HTg peptides 
To determine pathogenicity, five SJL mice were directly primed and boosted 
with HTg(2695-13) in adjuvant as described in Materials and Methods. Five weeks 
after the initial challenge with HTg(2695-13), MNC infiltration could not be 
detected in the thyroids of any of the five mice (Table 6. 3). In contrast, similar 
challenge of mice with MTg(2695-13) was shown previously to cause significant 
thyroid infiltration (Carayanniotis et al., 1994). Interestingly, however, pooled 
sera from the HTg(2695-13)-primed mice contained peptide-specific IgG. These 
IgG bound to the 12mer HTg (2695-06) and also cross-reacted with MTg(2695-06) 
(Table 6. 3). Thus, at the serological level, the human 18mer homologue is clearly 
immunogenic and contains B-cell epitopes that cross-react with their 
counterparts in the rat sequence. 
Adoptive transfer of 2xl07 HTg(2695-13)-primed LNC into syngeneic naive 
SJL hosts resulted in detectable thyroiditis in three out of four mice (Table 6. 3). 
However, the degree of infiltration induced by HTg(2695-13)-spedfic cells was 
low and is in contrast to the severe EAT previously induced with MTg(2695-13)-
specific LNC (Carayanniotis et al., 1994). Analogous results were observed when 
LNC primed to the rat or human (2695-06) 12mer peptides were used in adoptive 
transfer studies. Extensive infiltration was observed in all 6 mice that received 
MTg(2695-06)-specific LNC, whereas only small perivascular foci of MNC were 
Table 6. 3 EAT and serum IgG-responses in SJL mice challenged with homologous mouse and human Tg peptides 
Method of 
induction* 
By direct challenge 
0 
HTg(2695-13) + CFA 5 
CFA (control) 
By adoptive transfer 
HTg(2695-13) 
HTg(2695-06) 
MTg(2695-06) 
OVA (control) 
5 
1 
1 
7 
Infiltration Index 
1 2 3 4 
2 1 
0 3 
5 1 
Mice 
with 
EAT+ 
0/5 
0/5 
3/4 
3/4 
6/6 
0/7 
Serum IgG response (0. D. @ 405 nm) to 1 
HTg(2695-06) MTg(2695-06) 
1:20'~ 1:80 1:20 1:80 
2.50 1.11 2.84 1.50 
0.12 0.14 0.11 0.10 
0.44 0.16 0.34 0.19 
0.19 0.11 0.14 0.10 
0.45 0.19 0.64 0.23 
0.23 0.08 0.37 0.09 
*Direct EAT was induced by twos. c. injections of HTg(2695-13) as described in Materials and Methods. For adoptive 
transfer, 2 x 107 inguinal LNC primed in vivo and restimulated in vitro with the indicated antigen were i.p. injected. 
t Thyroids and sera were collected from mice 5 weeks after direct challenge with peptide or 2 weeks after cell transfer. 
1 Peptide-specific lgG response in pooled sera from each group was assessed by an alkaline-phosphatase based ELISA. 
Microtiter wells were coated with 8 Jig of human or mouse Tg(2695-06) peptide as described in Materials and Methods. 
¥Serum dilutions tested. 
..... 
N 
N 
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observed in 3 out of 4 mice that received lymphoid cells primed with HTg(2695-
06). These effects were antigen-specific because none of the 7 mice tested 
developed thyroiditis following transfer of OVA-specific LNC. Low titers of 
peptide-specific IgG were detected in some recipient mouse sera probably due to 
the co-transfer of activated B-cells in the LNC inoculum. 
6. 4 DISCUSSION 
The reliance on heterologous Tg sequences in our search for pathogenic T-
cell epitopes in mouse EAT has so far yielded successful results (Hutchings et al., 
1992; Texier, 1992; Chronopoulou and Carayanniotis, 1992; Carayanniotis et al., 
1994; Hoshioka et al., 1993; Kong et al., 1995; also, Chapter 4). The search 
strategies have involved testing of conserved peptides surrounding 
hormonogenic sites (Hutchings et al., 1992; Kong et al., 1995), peptides from the 
RTg sequence which are, on a phylogenetic basis, likely to be identical with 
mouse pathogenic epitopes Chronopoulou and Carayanniotis, 1992; 
Carayanniotis et al., 1994; Chapter 4) or peptides from the HTg sequence which 
are similar to other heterologous Tg fragments (Texier et al., 1992) or to peptides 
from other molecules such as hTPO (Hoshioka et al., 1993). The results of the 
present study, however, demonstrate that the thyroiditogenic RTg(2695-06) 
peptide and its human homologue, carrying two Ser substitutions at Gln2703 and 
Thr2704, do not have similar immunopathogenic properties. The human peptide 
is not detectable in proliferation or lymphokine assays and exhibits very weak 
pathogenicity demonstrable only by adoptive transfer of peptide-specific LNC. 
This raises caution in extrapolating pathogenic sequence data from one 
heterologous Tg to another even when EAT is induced within the same strain 
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and, in fact, when the given epitopes are presented in the context of the same H-
2-restriction molecule - in this case As (Carayanniotis et al., 1994). 
The two Ser substitutions at the carboxyl end of the human analogue may 
interfere with TCR engagement resulting in the triggering of non proliferative, 
autoreactive T-cell subsets that do not secrete IL-2 or IFN-y, unlike those 
activated by MTg(2695-06). This hypothesis can explain the lack. of cross 
stimulation by the two peptides as assessed by proliferation or by the activation 
of the IL-2-secreting 6E10 clone. It may also account for the differences in the 
severity of the adoptively transferred EAT, as a result of qualitative and/or 
quantitative differences at the level of inflammatory effector cells elicited by 
HTg(2695-06). Single a. a. substitutions in peptides of basic myelin protein are 
known to modify pathogenicity (Kibler et al., 1977), to modulate cytokine pattern 
secretion in autoreactive T cells (Windhagen et al., 1995), or to prevent EAE 
induction by the encephalitogenic analogue (Smilek et al., 1991). 
The capacity of the HTg(2695-06) to elicit weak EAT by adoptive transfer of 
non proliferative LNC is in agreement with similar observations in experimental 
uveoretinitis showing that pathogenic peptides of the 5-Ag do not stimulate 
proliferative responses (Gregerson et al., 1989) and with results of experimental 
autoimmune encephalomyelitis studies using MBP (Hunter, 1986). Other Tg 
peptides, such as the Ak-restricted RTg(2499-07), also exhibit weak 
thyroiditogenicity but fail to elicit proliferative LNC responses (Chapter 4 
section 4. 3. 5). In addition, the pathogenicity of Tg(2549-60) peptides, containing 
either T4 or TO at position 2553, has been shown only by adoptive transfer of 
peptide-specific lymphoid cells and not by direct challenge (Hutchings et al., 
1992; Kong et al., 1995). These observations are reminiscent of earlier results 
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describing EAT induction by adoptive-transfer of BTg-specific T-cell lines 
(Maron et al., 1983) but not by intact BTg in adjuvant (Romball and Weigle, 1984). 
The mechanisms underlying these phenomena remain elusive but more 
extensive lymphokine analysis of clonal T -cell populations responding to 
minimal pathogenic Tg peptides should elucidate the nature of non proliferative 
effector cells in EAT. 
Taken together, these data strongly suggest that screening for EAT-causing 
T -cell epitopes should combine several approaches including in vitro assays of 
proliferation and lymphokine analysis, direct challenge of mice with candidate 
peptides, as well as in vivo adoptive transfer of peptide-specific T cells, before 
conclusions concerning the pathogenicity of a given epitope can be made. In 
epitope mapping studies, the emphasis needs to be placed in EAT induced by 
homologous antigens and rat EAT currently provides an ideal choice for this; in 
that regard, the only peptide that has been tested for pathogenicity in a 
homologous host is the 17mer Tg(2495-11) that induced EAT in several strains of 
rats (Balasa and Carayanniotis, 1993). Because of its phylogenetic proximity, the 
partial RTg sequence also offers a good choice for epitope mapping in mouse 
EAT but, by extrapolation from other models (Zamvil et al., 1986), disparity at 
single a. a. positions may still lead to detection of RTg T-cell determinants of no 
relevance to mouse EAT. 
CHAPTER 7 
THYROIDITIS INDUCTION BY ADENOVIRAL PEPTIDE THROUGH 
MOLECULAR MIMICRY 
7.1 SUMMARY 
A computer search of SWIS5-PROT data bank was undertaken to identify 
sequences highly homologous with pathogenic Tg epitopes: MTg(2496-04) and 
MTg(2695-06). Since adenovirus infections were previously suspected in patients 
with subacute thyroiditis, we examined in the present study if a peptide from 
murine adenovirus type-1 ElB sequence (a. a. 368-81) (AVP) exhibiting a high 
degree of homology with the MTg(2695-06) mediates EAT in mice. The A VP was 
highly antigenic in vitro as it induced strong recall proliferative responses in 
MTg(2695-13) or MTg(2695-06)-primed LNC. In addition, AVP stimulated the 
AS-restricted T-cell hybrid clone 6E10 and, in ELISA it significantly bound to 
MTg(2695-13)-specific serum IgG. A VP, however, was a poor immunogen failing 
consistently to induce LNC-proliferative responses or mediate EAT directly in 
SJL hosts. Nevertheless, in preliminary experiments, it was found that MTg(2695-
06)-primed LNC upon culture with A VP acquired the ability to adoptively 
transfer severe EAT in SJL hosts. In light of these findings, we propose that viral 
peptides such as A VP, when generated during viral infections, may mimic host 
Tg-epitopes leading to activation and amplification of autoreactive T cells in 
AITD. 
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7. 2 INTRODUCTION 
Despite the impressive progress made in the last two decades in molecular 
characterization of the immune system, the etiopathogenesis of many human 
autoimmune diseases still remains elusive. Growing evidence points to infection 
by microbes as an important cause of AITD (Tomer and Davies, 1995) and 
several reports on association of viral infections with the development of 
thyroiditis exist (Eylan et al., 1957; McArthur, 1964; Hung, 1969; Volpe, 1975; 
Martino et al., 1987 and deBruin et al., 1990). However, it remains speculative as 
to why only some of the infected individuals develop thyroid autoimmunity 
during the post-infection period (Tomer and Davies, 1993). 
Several studies point to T cells having a pivotal role in the pathogenesis of 
autoimmune thyroiditis and the characterization of thyroiditogenic T-cell 
epitopes has strongly supported this view (Carayanniotis and Rao, 1997). 
Peptide recognition by T cells seems to be highly degenerate (Bharadwaj et al., 
1993) and often involves TCR contact with a few a. a . residues of the peptide 
(Gautam et al., 1992; Wraith et al., 1992; Boehncke et al., 1993). Thus it is possible 
that molecular mimicry involving only partial identity between host and 
microbial Ag is sufficient to drive autoreactive immune responses. For example, 
a hepatitis B virus polymerase-derived peptide identified based on its homology 
with a pathogenic site on MBP was shown to induce infiltration of central 
nervous system in rabbits, a characteristic sign of EAE (Fujinami and Oldstone, 
1985). Molecular mimicry by microbial proteins was similarly incriminated in the 
etiopathogenesis of many other autoimmune diseases including myasthenia 
gravis (Dieperink and Stefansson 1989), autoimmune oophoritis (Tung, 1994; 
Garza and Tung, 1995), celiac disease (Kagnoff, 1989; Tuckova et al., 1995), 
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juvenile rheumatoid arthritis (Albani, 1994), insulin dependent diabetes mellitus 
(Atkinson et al., 1994) and experimental autoimmune uveitis (Singh et al., 1990). 
Our previous work in EAT has demonstrated that MTg(2695-06) is a 
pathogenic T-cell site and mediates EAT (Chapter 6, section 6. 3. 6). In this 
chapter I have examined the concept of molecular mimicry using a viral peptide 
(A VP), identified based on its homology with MTg(2695-06). Data are presented 
in support of the hypothesis that peptides such as A VP, can activate, via 
molecular mimicry, autoreactive T cells reactive with host Tg-epitopes thereby 
leading to induction of thyroiditis. 
7. 3 RESULTS 
7. 3. 1 Homology comparison of MTg(2496-04) and MTg(2695-13) with 
sequences in SWISS-PROT data bank 
To identify "molecular mimics" between microbial antigens and pathogenic 
Tg epitopes, we scanned SWISS-PROT data bank for sequences that show 
significant homology with pathogenic Tg T-cell epitopes: (2496-04) and (2695-13). 
The search results comprising the top five sequences along with their homology 
scores against the appropriate Tg-peptide are presented in Table 7. 1. Out of the 
five sequences that scored >40% homology with Tg(2496-04), four showed an 
overlap of all nine residues whereas the sequence from human myosin heavy 
chain precursor presented an overlap of only eight residues. The sequences with 
the highest% homology were from the yeast cytoplasmic transport protein and 
human myosin heavy chain precursor. Of the other three sequences scoring 
same degree of homology (i.e., 44. 4%), one was derived from E. coli while the 
Table 7. 1 Homology comparison of MTg(2496-04) and MTg(2695-13) with sequences in SWISs-PROT data bank 
Sequence a Protein % Homology Overlap 
LINRAKAVK Mouse thyroglobulin 100 
LIGHA~AVK Cytoplasmic transport protein (yeast) 66.7 
LIT QVRSVK Diaminopimelate decarboxylase (E. coli) 44.4 
LIL.RI.QAVC Human fast skeletal muscle myosin 
LIQ PDS S VK Human fibrinogen beta chain precursor 
LIS MI Q.YVK Human leukocyte common antigen 
precursor 
C SF W SKY I Q T L K D A D G A K Mouse thyroglobulin 
KYIQALKG DNA-directed RNA pol 
SF YS ,S_YIQTLI_VAQ Adenovirus E1 B-protein 
SFWG..E_Ay_QT Retrovirus pol protein 
CSFWNDYLPKVR Acetyl cholinesterase precursor 
TFWQQ.EGL VLKEG Heat shock protein 
a A total of26, 706 sequences in the data base were searched. 
Bold letters denote residues identical with the Tg peptide. 
Underlined letters denote conservative substitutions. 
62.5 
44.4 
44. 4 
100 
75.0 
64.3 
55.6 
41.7 
30.8 
9 
9 
9 
8 
9 
9 
18 
8 
14 
9 
12 
13 
Reference 
(Kuppers et al., 1996) 
(Hicke and Schekman, 1989) 
(Stragier et al., 1983) 
(Eller et al., 1989) 
(Watt et al., 1979) 
(Streuli et al., 1987) 
(Kuppers et al., 1996) 
(Oeser and Tudzynski, 1989) 
(Ballet al., 1988) 
(Grandbastien et al., 1989 
(Fournier et al., 1989) 
(Bardwell and Craig, 1987) 
..... 
N 
I.C 
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other two were human proteins (fibrinogen ~-chain precursor and CD 45) (Table 
7. 1). 
Out of five different sequences that scored >30% homology with Tg(2695-
06), two sequences were from viruses (adenoviral ElB protein and retroviral pol 
protein), one is from bacteria (E. coli heat shock protein), another one is from 
DNA-directed RNA pol while the last sequence is from acetylcholinesterase 
precursor, another autoantigen (Table 7. 1). Interestingly, the adenoviral 
EIB(368-381) sequence shows significant homology (64.3% in a overlap of 14 
residues) with the N-terminal 12 a. a. sequence of the MTg(2695-13). As 
described in chapter 6, the N-terminal region (2695-06) encompasses an 
immunopathogenic T -cell epitope(s) in SJL hosts. Hence, we proceeded to test 
whether the adenoviral ElB-peptide (A VP) sharing sequence homology (64.3% in 
a overlap of 14 residues) with the epitope MTg(2695-06) would be 
immunologically cross-reactive at B- or T-celllevel. Studies with A VP are also 
relevant, since an increased incidence of adenovirus infections was noted 
previously in patients with subacute thyroiditis (Volpe et all967). 
7. 3. 2 A VP is recognized by MTg(2695-13)-specific LNC or T -cell clone 6E10 
Initially, we sought to determine whether or not the 14mer AVP can be 
recognized by Tg(2695-13)- or Tg(2695-06)- primed LNC in vitro. Mice were 
primed with Tg(2695-13) or Tg(2695-06) in CFA and proliferation assays of 
inguinal LNC were subsequently done as described earlier. A VP was found to be 
recognized by Tg(2695-13)-specific LNC as shown in Figure 7. 1. Expectedly, 
AVP was also recognized by MTg(2695-06)-primed LNC (in 3 out of 4 
experiments) Figure 7. 2 In addition, AVP was recognized by the T-cell hybrid 
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Figure 7. 1 Specific activation by AVP in vitro of MTg(2695-13)-primed 
LNC from SJL mice. Inguinal LNC from mice (2/group) primed s. c. with 
SO nmol of MTg(2695-13) 10 days earlier, were cultured in triplicate 
microwells in the presence of varying concentrations of antigen. Data (S. 
~- values) obtained from full titration curves are representative of two 
independent experiments. Background cprn were= 12,500 ± 2,100. 
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Figure 7. 2 LNC from MTg(2695-06)-primed SJL mice proliferate 
against A VP. Mice (2/ group) were primed s. c. with SO nmol of peptide 
and 10 d later, their inguinal LNC were cultured in the presence of 
varying concentrations of the antigens shown above. Data (mean cpm) 
representative of three independent experiments are shown. 
Background cpm were= 3,930. 
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6E10 (Table 7. 2) confirming cross-reactivity between MTg(2695-06) and AVP at 
the donal T-cell level. These data suggest that the three conservative a. a. 
substitutions i.e., Trp -> Tyr, Lys -> Ser, and Lys -> Thr at positions 2698, 2700 
and 2706 constitute residues that can be well tolerated in the recognition of 
Tg(2695-13) by AS -restricted T cells in SJL mice. 
7. 3. 3 MTg(2695-13)-specific IgG bind to A VP 
We next asked whether the AVP and MTg(2695-13) share B-cell epitopes as 
well. To test this, SJL mice were immunized with MTg(2695-13) and, after 35 
days, the serum IgG response against A VP was assayed by EUSA. The 
MTg(2695-13) elicited IgG bound to A VP as well as MTg(2695-06) (Figure 7. 3). 
In additional experiments (not shown) it was observed that serum IgG from mice 
that had received in adoptive transfer the MTg(2695-06)-specific LNC, also cross-
reacted with the viral peptide. These data clearly show the sharing of epitope(s) 
at the B- cell level between the pathogenic MTg(2695-06) and A VP. 
7. 3. 4 AVP is poorly immunogenic at T- and B- cell level 
The immunogenicity of A VP was next examined in SJL mice. Due to its 
high hydrophobic nature, A VP was not completely soluble in PBS and thus, the 
partially solubilized preparation was used initially for immunization. Ten days 
after priming, the in vitro proliferative response of inguinal LNC against A VP 
(14mer), MTg(2695-06) and MTg(2695-13) was assessed. In two out of four 
experiments, the LNC responded weakly to AVP 14mer but not to MTg(2695-06) 
or (2695-13). The data presented in Figure 7. 4 illustrate the data from one such 
Table 7. 2 A VP is recongized by MTg(2696-06)-specific T cell hybrid clone 6E10 
Peptide 
in vitro 
MT g(2696-06) 
AVP 
MTg(2701-13) 
(Control Ag) 
40 
5MZ±6.3 
12.67 ± 14 
1.32 ± 0.1 
CTLL proliferation (cpm x 10- 3) 
Antigen concentration (flg/ml) 
13.3 4.4 1.5 
12J.Q ± 2.7 40.21 ± 4.9 ~±3.9 
4.56 ± 0.6 2.92 ±0.3 2.64 ±O.fl 
1.41 ± 0.1 1.41 ± 0.1 1.41 ± 0.1 
105 LS 102.9 cells and an equal number of hybrid cells were cultured with the above 
mentioned antigens at the indicated concentrations. Culture supernatants after 24 h 
were assayed for IL-2 content as described in Materials and methods. 
Data represent mean cpm ± SD of triplicate wells. Background cpm were= 1, 444 ± 
0.10. 
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Figure 7. 3 A VP is recognized by MTg(2695-13)-specific IgG. Three 
mice were primed with MTg(2695-13) in CFA and their pooled 
serum was tested for specific~IgG against the indicated peptide Ag 
in an alkaline phosphatase-based ELISA (see Materials and Methods 
section 3. 4. 3 for details} Microtitre wells were coated with 8 IJ,g of 
peptide I well. Data represent mean O.D. of duplicate wells, while 
vertical bars represent SD. 
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Figure 7. 4 A VP can prime for proliferative LNC-reponse in SJL 
mice. Mice were primed s. c. at the base of the tail, with 50 nmol of 
A VP 14rner in CFA and, 10 d later, their inguinal LNC were 
cultured in the presence of varying concentrations of peptide Ag as 
shown above. Data represent S. I. values of triplicate wells. 
Background cpm were = 6, 605. 
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experiment. The LNC proliferation is only moderate against A VP (S. I. = 4.0) and 
is completely lacking against MTg(2695-13) or MTg(2695-06). To examine if the 
poor immunogenicity of A VP was due to poor solubility in aqueous media, 
simultaneous priming of mice with A VP in PBS or in DMSO was undertaken. 
The poor immunogenicity of AVP is evident from the data shown in Table 7. 3. 
Neither the PB5- (Experiments I & ll) nor DMSO- (Experiments ill & IV) 
preparations of A VP elicited a specific-LNC response. To rule out the possibility 
that DMSO may have had negative effects (if any) on the priming by AVP, mice 
were immunized in parallel with DMSO-dissolved MTg(2695-06) and their LNC-
proliferative response against MTg(2695-06) was assessed (data not shown). The 
S. I. values against 10 J.Lg/ml concentration ofMTg(2695-06) and PPD were in the 
range of 4- 6 and 12-15 respectively. These data, as well as the highS. I. values 
observed against PPD in the experiments ill and IV of Table 7. 3 clearly argue 
against any deleterious effects of DMSO on peptide priming in the current study. 
To test whether AVP-priming might induce specific IgG in SJL hosts, sera 
were collected from 5 mice that were primed and boosted with A VP-dissolved in 
DMSO. ELISA performed on sera revealed no specific IgG to the viral peptide 
(data not shown). 
7. 3. 5 Adoptive transfer of EAT 
Some Tg peptides can mediate EAT by adoptive transfer of specific LNC, 
although they fail to induce proliferative LNC responses or pathology following 
direct challenge in mice with peptide (Hutchings et al., 1992; Chapter 6, section 
6. 3. 7). Therefore, we examined the pathogenicity of A VP in adoptive transfer 
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Table 7. 3 Lack of specific proliferative response of LNC from SJL mice 
primed with A VP 
Proliferative response b against 
Agdose 
Experiment a (Jlg/ml) AVP MTg(2695-06) MTg(2695- 13) 
AVP in PBS+ CPA 
Exp. I 40 1.31 ND ND 
10 1.55 1.61 1.32 
2.5 NO 1.44 1.58 
Exp.II 40 1.08 0.99 1.32 
10 0.87 1.42 1.08 
2.5 NO 1.05 1.04 
A VP in DMSO+ CFA 
Exp.m 5 1.49 0.95 1.11 
0.5 1.15 1.01 0.94 
0.05 0.86 0.99 0.89 
Exp. IV 5 1.22 0.89 0.93 
0.5 1.02 0.73 0.76 
0.05 0.89 0.83 0.89 
aMice (2/group) were injected s. c. at the base of the tail with 50 nmol of 
A VP 14mer in CPA and ten days later their inguinal LNC were allowed to 
proliferate against the indicated doses of Ag as mentioned above. 
boata represent S.l. values of triplicate wells. Background cpm were: exp. I 
= 1906; exp. II = 1140; exp. III = 1995 and exp. IV= 2536; Against PPD (10 
Jlg mi-l) the S. I. values were: exp. I= 27. 27; exp. II= 25.17; exp. III= 20.99 
and exp. IV= 16.28. 
Table 7. 4 A VP• mediates adoptive transfer of EAT 
In vivo 
Group immunogen 
1. 
2. 
3. 
AVP 
MTg(2695-06) 
MTg(2695-06) 
In vitro 
stimulation 
with 
AVP 
AVP 
0 
6 
1 
5 
Infiltration Index 
0.5 1 2 
1 
1 3 
3 
1 
Mice 
with 
EAT 
1/7 
5/6 
0/5 
For EAT induction adoptive transfer of 2"3 x to7 peptide"specific cells was carried out as 
described in Materials and Methods. Fourteen days after the transfer, thyroid glands were collected 
for histological examination. 
• A VP lOmer was used. 
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Table 7. 5 Physico-chemical characteristics of A VP and MTg(2695-06) • 
A VP MTg(2695-06) 
Parameter 14mer 10mer 
Molecular weight 1608 1208 1504 
Isoelectric point 5.25 6.12 10.03 
Half-life in vitro 
mammalian reticulocytes 1.9 hr 1.9 hr 1.2 hr 
Half-life in vivo 
yeast >20hr >20hr >20hr 
E. coli > lOhr > lOhr > lOhr 
• Physicochemical characteristics estimated according to the 
PHYSICOCHEM program of PC/GENE (IntelliGenetics, Mountain View, 
CA, USA) 
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experiments. A !Orner peptide was used in these experiments, since work in 
parallel had established that deletion of the four C-terminal residues (Thr, Val, 
Ala and Gln) within the 14mer A VP did not affect the peptide-specific activation 
of the T cell hybrid 6E10 (data not shown). Of the three groups of recipient mice, 
the first group received LNC primed in vivo and boosted in vitro with A VP, while 
the other two groups received MTg(2695:-0t'}-primed LNC after culturing in the 
presence of either A VP (group 2) or medium alone (group 3). The data on 
adoptive transfer of EAT are presented in Table 7. 4. One out of seven mice 
(group 1) that received A VP-primed and -boosted LNC exhibited focal 
thyroiditis. On the other hand, EAT was seen in six out of seven mice that 
received MTg(2695-06)-primed LNC following a boost in vitro by A VP. In 
contrast, all five control mice (group 3) that received MTg(2695-06)-primed LNC 
without A VP-boosting in vitro did not develop EAT. These findings highlight the 
potential of viral pep tides such as A VP to induce thyroiditis, by virtue of their 
cross-reactivity at T-celllevel and, provide an example of EAT induction via 
molecular mimicry. 
7. 4 DISCUSSION 
We have shown that a viral peptide can amplify pathogenic T cells specific 
for a cryptic Tg-peptide leading to induction of thyroiditis in mice. The 
relationship between viral infections and autoimmunity is complex: viruses can 
unveil privileged self-antigens or modulate antigen processing leading to 
expression of cryptic epitopes and in genetically susceptible hosts they may 
induce autoimmunity (Barnaba, 1996). It is not known if adenovirus type 1 
infection in mice can lead to development of thyroid autoimmunity. In human 
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studies, mumps (Eylan et al., 1957) and Epstein-Barr (Coyle et al., 1989) viruses 
were implicated in the causation of subacute thyroiditis, while the presence of 
antibodies to influenza, coxsackie, mumps, and ECHO and adenoviruses was 
recorded in sera from patients with proven subacute thyroiditis in another study 
(Volpe et al., 1967). However, to date no particular virus has been clearly shown 
to be associated with the etiology of autoimmune thyroiditis in humans or 
animal models. 
Previously we noted that the human homologue of MTg(2695-06) differing 
at only two residues Gln2703 and Thr2704 showed no cross-reactivity at T-cell 
level and exhibited contrasting immunopathogenic properties (Chapter 6). We 
hypothesized that these residues may act as important contact sites for the cross-
reactive TCR or for binding to MHC. Such a view is supported by the present 
study because 10mer AVP is identical to MTg(2695-06) at eight positions 
including Gln2703 and Thr2704. Grafting of residues individually from the 
MTg(2695-06) sequence on to a backbone of alanine residues, may reveal within 
the pathogenic peptide the key positions for MHC and TCR, as earlier reported 
in EAE by Gautam and co-workers (1992). Knowledge of the structural 
requirements for both MHC binding and TCR recognition has further allowed 
identification of several molecular mimicry peptides by Wucherpfennig and 
Strominger (1995), and facilitated the construction of combinatorial peptide 
libraries as tools by Hemmer and co-workers (1997) to identify multiple cross-
reactive ligands for MBP-specific T cells. 
The present study delineates the E1B(368-81) sequence of murine 
adenovirus type 1 as aT-cell epitope site that mimics a pathogenic cryptic Tg 
epitope. A VP is cross-reactive at B-andT- cell level with MTg(2695-06) but is a 
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poor immunogen. The reasons behind this puzzling observation are not well 
understood. Lack of affinity to MHC does not seem to explain the poor 
imm.unogenicity of A VP since the T-cell clone (6El0) responded equally well to 
both A VP and MTg(2695-06). It is, however, possible that inclusion of additional 
(N- or C-terminal) residues may enhance the immunogenicity of AVP. 
Analogous data on the importance of flanking sequences on the immunogenicity 
of a measles epitope were reported by Partidos and Steward (1992). In contrast 
to MTg(2695-06), A VP may have a shorter half-life in vivo but this is rather 
unlikely, since A VP was able to prime for specific LNC proliferative response in 
one experiment (Figure 7. 4) and as shown in Table 7. 5, the half-life values of 
A VP 14mer or 10mer are not significantly different from those of MTg(2695-06). 
The present study provides evidence for the first time in the field of EAT, 
that thyroid pathology in mice can result due to molecular mimicry by a viral 
peptide. It remains to be tested if the other sequences that scored significant 
homology with MTg(2695-06) (Table 7. 1) will be cross-reactive and/ or 
thyroiditogenic as well. Based on the pathogenicity data of A VP we hypothesize 
that T-cell peptides, that are cross-reactive with and can mimic pathogenic 
epitopes on autoantigens, need not necessarily induce detectable immune 
responses to themselves and, that the pathogenic potential of such peptides 
could become apparent following infection in disease-susceptible subjects with 
pre-existing autoreactive immune responses. Regardless of the mechanisms 
involved, the present data underscore the possibility of induction of thyroiditis 
via molecular mimicry by non-self peptides. 
CHAPTER 8 
FUTURE DIRECTIONS 
The present study was initiated following the observation that the 17mer 
Tg(2495-11) induces thyroiditis in H-2k mice. The questions raised at the 
beginning of the study were: (a) what is the phenotypic profile and MHC-
restriction property of MTg(2495-11)-specific T cells ? (b) where are the 
pathogenic T-cell determinant(s) located within MTg(2495-11) ? (c) doT cells 
recognizing a minimal pathogenic peptide:MHC complex belong to Thl or Th2 
phenotype and are TCR on such cells genetically restricted ? In a later phase of 
the study, the observation that the Tg-peptide (2695-13) induces thyroiditis only 
in SJL mice, spurred a different set of questions: (a) Is a human homologue of 
MTg(2695-13) immunopathogenic as well? and (b) can a viral sequence showing 
homology with MTg(2695-06) contribute to EAT development via molecular 
mimicry? The data obtained have answered these questions but generated a set 
of new questions. 
For example dwing the present study Tg(2496-04) has been characterized as 
minimal T-cell epitope that can elicit autoreactive T cells in C3H and SJL mice. 
Also it was shown that such T cells resemble Thl cells by secreting IL-2 and IFN-
r but not IL-4 although it is possible that such cells secrete other lymphokines 
(not assayed for in the present study). Alternatively, using RT -PCR, the 
lymphokine gene expression among thyroid infiltrating lymphocytes (at different 
time points) in mice challenged with Tg(2496-04) can be assessed. Once the 
knowledge of the key lymphokine(s) secreting T -cell subset(s) becomes available, 
whether or not mice lacking genes for a particular (set of) lymphokine(s) will 
145 
develop EAT after peptide challenge will further confirm their role in EAT. 
The studies of Braley-Mullen and co-workers showed that granulomatous, 
as opposed to lymphocytic EAT, develops in mice following adoptive transfer of 
Tg-primed LNC that are boosted in vitro with Tg in cultures containing anti-IL-
2R Abs (Braley-Mullen et al., 1991; McMurray et al., 1994). It is not dear in their 
studies whether or not the granulomatous EAT -inducing LNC subset(s) is 
different from the subset(s) responsible for inducing lymphocytic EAT, in terms 
of their antigen fine specificity. Anti-IL-2R treatment of LNC might selectively 
promote activation and growth of a subset of LNC whose antigen fine 
specificities are different from those inducing lymphocytic thyroiditis. Whether 
or not the granulomatous EAT phenotype is a true reflection of the anti-IL-2R 
treatment on the effector T cells, can be easily clarified by adoptively transferring 
Tg(2496-04)-specific LNC treated with or without anti-IL-2R mAb. Finally 
studies focused on the intracellular signaling events in the T cells of a defined 
specificity, which participate in the granulomatous as opposed to lymphocytic 
thyroiditis, may aid in our understanding of the immunoregulation of EAT. 
The findings that epitopes of MTg(2499-07) or (2695-06) are cryptic in the 
context of whole Tg, as shown by lack of activation of the appropriate specific T-
cell hybridomas by APC pulsed with MTg (see sections 5. 3. 4 & 6. 3. 2) confirms 
the previous results (Chronopoulou and Carayanniotis 1992; Carayanniotis et al., 
1994). The hybridomas generated and characterized in the present study are 
invaluable tools for future antigen presentation studies. For example, the 
assumption that these apparently cryptic epitopes (2496-06) or (2695-Q6) must be 
generated and expressed by intra-thyroidal APC to allow thyroid specific 
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homing of the effector cells, can be tested using the T-cell hybridomas. 
Activation of the T cells by thyroidal epithelial cells or thyroid-derived APC such 
as dendritic cells (of course, all expressing MHC class IT plus appropriate co-
stimulatory ligands) will be a direct evidence in support of the above 
assumption. Iodination of Tg has been shown to alter its structure and possibly 
its immunogenicity. It will be worthwhile to examine if varying degrees of 
iodination of Tg would make a difference in the generation these epitopes. 
Alternatively, extracts of limited digestion by thyroid lysosomal cathepsins of Tg 
that is iodinated to a varying degree, can be tested for their capacity to activate 
the hybridomas. Another approach to test whether or not processing of Tg by 
APC in vivo will generate the cryptic epitopes, could be to immunize mice with 
whole Tg in adjuvant and 6-7 days later use the draining LNC as APC to activate 
the hybridomas in culture without adding Tg or peptide exogeneously. 
The inability of homologous but not heterologous Tg to induce proliferative 
LNC responses has been attributed to suppressor T -cell determinants. This can 
be tested now by co-culturing of (2496-04)- or (2695-06)- primed LNC with 
homologous (mouse) or heterologous (rat) Tg -primed LNC in medium 
containing the immunizing peptide and Tg. Peptide-specific LNC proliferation 
should not be suppressed in cultures that had rat Tg-primed cells, but on the 
other hand, should be suppressed in cultures where mouse Tg-primed LNC were 
added. As a control, cultures should be set up where only peptide-specific LNC 
are allowed to respond to the immunizing peptide in doses equivalent to those 
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used in LNC-mixing experiments as described above. In additional experiments, 
culture supernatants from mouse or rat Tg-activated LNC cultures can be 
assayed similarly for suppressive effects (if any) on peptide-specific LNC 
proliferation assays. 
In the present study it has been demonstrated that (2695-06) constitutes an 
AS-restricted, pathogenic site on MTg encompassing highly immunogenic 
epitope(s) that elicit cells of Thl type. The contrasting findings, however, that the 
human homologue of this sequence is non-immunogenic in SJL hosts raise some 
interesting questions: Is the human Tg(2695-06) capable of inducing proliferative 
LNC responses in mice of other (k, d, b or q) haplotypes ? Is one or both serine 
substitutions in the human homologue at positions 2703Gln and 2704Thr 
responsible for the observed lack of immunogenicity and/ or pathogenicity in 
mice. What are the key residues within (2695-06) that are responsible for MHC 
binding? Are they distinct from those contacting the TCR on pathogenic Thl 
cells? These studies eventually may help in designing and testing of peptide 
analogues with therapeutic potential in EAT. Also, it remains to be tested if 
HTg(2695-13) or (2695-06) can be recognized by sera or T cells from HT patients. 
Finally, the work involving identification of an adenoviral ElB-derived 
peptide (A VP) that is immunologically cross-reactive at B- and T -cell level with a 
Tg-epitope present in the peptide (2695-06) raises new interesting questions. Can 
adenovirus infection in mice lead to thyroiditis and an A VP-specific B- or T- cell 
response ? Is A VP a site for dominant T -cell epitope on the El B protein ? Also 
the question whether a cryptic Tg-epitope can be mimicked by a dominant viral 
epitope can now be addressed by assaying the activation ofT-cell hybridoma 
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(6E10) in cultures containing APC incubated with EIB protein. Alternatively, 
APC expressing EIB protein, following transfection with ElB-cDNA, may be 
used in the hybridoma activation assays. 
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